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This thesis describes an observational study of renal 
function in preterm babies. During the course of the study 
no attempt was made to manipulate clinical conditions. The 
study was performed in three parts. 
The principal portion of the work was an observation 
of renal function during the first week of life, in a group 
of infants between 25 -34 weeks gestation, who required 
intensive care; the influence of gestational age, postnatal 
age, birth weight and respiratory adaptation were explored. 
Comparison is made with published parameters of renal 
function derived from healthy preterm neonates. 
Glomerular filtration rate was assessed as endogenous 
creatinine clearance during prolonged urine collection. No 
increase in glomerular filtration rate was shown between 
days 2 -7 of life. The population of infants studied here, 
who required intensive care, showed little difference from 
published parameters of glomerular filtration rate measured 
in healthy preterms. 
Creatinine excretion rate was used to derive a 
regression equation predicting muscle mass from weight and 
gestational age. Muscle mass was found to increase from 12% 
of birth weight at 25 weeks gestation to 19% at 34 weeks 
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and 24% at 40 weeks. This is in agreement with classic 
dissection studies which have shown muscle mass to be 25% 
of body weight at term. 
Changes in urine flow rate, urine osmolality and 
sodium balance were studied. The influence of respiratory 
adaptation on various parameters of renal function and 
particularly on sodium handling was investigated. Positive 
sodium retention was seen in babies with respiratory 
disease; sodium retention changed to sodium loss at a point 
coinciding with improvement in respiratory function. The 
diuresis that accompanied the improvement in respiratory 
function, in infants with hyaline membrane disease, was 
characterised as a natriuresis, with increased creatinine 
clearance and osmolar clearance but unchanged free water 
clearance. 
Renal function was compared during periods of 
hyperglycaemia and normoglycaemia. The degree of 
hyperglycaemia observed did not result in an osmotic 
diuresis but was associated with a significant decrease in 
fractional sodium excretion and urinary sodium loss. 
The second part of the study determined the incidence, 
aetiology, diagnostic indices and outcome of acute renal 
failure in a series of 388 consecutive admissions. The 
incidence in this tertiary referral centre was found to be 
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6.2 %. The difficulties involved in making an accurate 
diagnosis of acute renal failure are examined. 
In the third part of this work serum 
beta -2- microglobulin was studied in a group of 'well' 
preterm babies and its value as an index of glomerular 
filtration rate assessed. 
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Neonatal Intensive Care 
The care of the immature infant now constitutes the 
major workload of neonatal intensive care units. Although 
only approximately 0.9% of all live born babies in this 
country are below 1500 g birth weight, these infants take 
up about 50% of the total cot days required for intensive 
care [Royal College of Physicians of London 1988]. In 
addition to increasing complexity of intensive care 
practice, the number of babies requiring intensive care is 
also rising. The number of livebirths of less than 1500 g 
birthweight has risen by 29% between 1981 and 1986 [Royal 
College of Physicians of London 1988]. The technological 
and medical skills necessary have largely developed over 
the last decade, during which time the survival of such 
infants has improved dramatically. In England and Wales the 
neonatal survival rate of babies less than 1000 g birth 
weight has increased from 21.4% in 1975 to 47.6% in 1985 
and that of babies between 1000 -1499 g from 62.6% to 86.4% 
[Royal College of Physicians of London 1988]. However as 
the limits of viability are pushed further back the 
neonatal paediatrician is faced with the problems of 
both greater organ immaturity and of superimposed 
pathology. 
Neonatal intensive care in the United Kingdom is 
generally held to have begun in the late 1970s. In the 
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development of neonatal intensive care the initial thrust 
was concerned primarily with the problems of ventilation. 
Assisted ventilation as routine management for babies with 
respiratory failure evolved from a research basis in 
the 1960s. Subsequently the advent of real time ultrasound 
revealed the extent of intracranial sequelae and research 
centred in this area; this was the herald for snowballing 
advances in other brain imaging and neurological 
investigatory techniques which have led to a better 
understanding of neurodevelopmental morbidity in preterm 
and asphyxiated neonates. In relative terms, little 
attention was afforded other systems. 
The tiny, immature infant 
A typical infant, of extreme immaturity, to be found 
in today's neonatal intensive care units is likely to be 
receiving ventilatory support, total or partial parenteral 
nutrition and to have continuous monitoring of a number of 
physiological variables including paO2, paCO2, blood 
pressure, skin temperature and ECG. Intravenous and 
intraarterial access will be available and the infant will 
be nursed beneath a radiant warmer or in an incubator. 
Disturbances of fluid and electrolyte balance are 
common in such infants; physiological data are difficult 
to obtain. Simple measurements are made difficult by the 
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small size and frailty of the infants. The blood volume of 
approximately 75 ml kg -1 requires the development of 
microassay techniques. Blood specimens are obtained from 
indwelling lines or from heelprick; in the former there is 
the risk of contamination by infusate, in the latter of 
obtaining a haemolysed specimen. 
Urine collection poses a particular problem. Standard 
self adhesive urine collection bags are often too large for 
the smallest infants and, in the moist environment of their 
use, leakages frequently occur. Preterm infants have 
extremely thin, friable skin and breakdown of the skin of 
the perineum, thighs 
do not empty their 
rendering external 
inaccurate. Bladder 
and groins is a real problem. Neonates 
bladders completely on voiding, 
urine collections of short duration, 
catheterisation is both difficult to 
carry out in the tiniest infants and ethically 
inacceptable as a routine, given the risks of trauma to 
delicate tissues and of introducing infection. 
Accurate weighing is essential in the assessment of 
fluid balance. A sick infant, possibly paralysed for 
ventilation, must be weighed rapidly. Beam and spring 
balances are both insufficiently accurate and slow to 
equilibrate. An electronic balance accurate to 2 -4 g is 
necessary, making meticulous allowance for the weights of 
a variety of monitoring electrodes, infusion cannulae, 
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endotracheal tube stabilisers and possibly chest drains. 
An extrauterine existence prior to term is an abnormal 
event and 'normality' in terms of physiological parameters 
is therefore difficult to define. 
Most very low birth weight infants require intensive 
care during the first days of life and there has been a 
reluctance to collect data during this period because of 
the complex clinical setting. Confining data collection to 
physiologically stable infants has had three consequences; 
early literature has a preponderance of small for 
gestational age babies of low birth weight but relative 
maturity because the distinction between low birth weight 
and preterm and low birth weight and small for 
gestational age was not appreciated until the 1960s [Butler 
& Bonham 1963]; subsequently studies of 'preterm' 
infants included disproportionate numbers of infants of 
moderate immaturity, i.e. of greater than 30 weeks 
gestation as opposed to those of extreme immaturity or 
less than 30 weeks gestation [Aperia & Zetterstrom 1982]; 
more recently workers have tended to study preterm infants 
of greater postnatal age, thus introducing the confounding 
variable of extrauterine maturation. The neonatal 
paediatrician has therefore been obliged to base 
management of fluid and electrolyte balance on data 
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extrapolated from infants of greater maturity or postnatal 
age or from animal studies. 
The primary aim of this study was to provide data 
relating to renal function and the clinical management of 
sodium and water balance in a typical group of infants 
requiring admission to a neonatal intensive care unit. No 
attempt was made to manipulate clinical conditions; rather, 
the form of the study was entirely observational. 
Three groups of infants were studied: firstly 
several parameters of renal function were evaluated during 
the first week of life in a group of infants between 25 -34 
weeks gestation who were receiving intensive care; 
secondly the incidence, aetiology, diagnostic indices and 
outcome of acute renal failure in a series of 388 
consecutive admissions to a neonatal intensive care unit 
were evaluated; thirdly serum beta- 2- microglobulin was 
studied in a group of 'well' preterm babies and its value 
as an index of glomerular filtration rate assessed. 
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THE DEVELOPMENT OF RENAL FUNCTION 
Present knowledge of renal function in the extremely 
immature infant has on the whole arisen from extrapolation 
from studies on immature animals and older human infants. 
There has been very little direct study of extremely 
immature infants in the first days of life and less of the 
human fetus in utero. This chapter will review the 
information available relating to the development of renal 
function in the extremely immature infant. Although 
investigations on animal models will be touched on, it is 
intended to concentrate here on features relating 
directly to the human fetus and neonate. 
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Anatomical development 
The development of human renal function and the 
definitive kidney is believed to proceed with the 
formation of the three excretory organs, the 
pronephros, mesonephros and metanephros. The pronephros 
has no excretory role, merely giving rise to the 
mesonephric duct; it arises at around the third week of 
gestation and involutes over the following fortnight. 
O'Rahilly and Muecke [1972] have shown that although 
nephrotomes become differentiated from the intermediate 
mesoderm at three weeks and are formed rostrally, they do 
not appear to be nephric tubules. These authors have 
therefore argued that "the concept of the pronephros does 
not apply to the human embryo ". The functional significance 
of the mesonephric kidney varies greatly between different 
mammalian species. The mesonephros comprises primitive 
tubules and glomeruli and in the human fetus, degenerates 
by the twelfth week [McCrory 1972]. There is overlap betwen 
the development of the mesonephros and the metanephros, 
with the first definitive nephrons arising from the 
metanephros in the fifth week and becoming functional by 
eight weeks. During the fifth week the blastema of the 
metanephros is penetrated by the ureteric bud, which will 
form the collecting system. 
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Nephrons are formed in a centrifugal manner with the 
first in the innermost region of the cortex. At 22 weeks 
all nephrons are juxtamedullary [Potter 1965]. By 35 weeks 
gestation each kidney contains the full complement of one 
million nephrons [MacDonald & Emery 1959]. Birth does not 
accelerate nephrogenesis [Potter & Thierstein 1943]. 
The renal blood supply is established by the ninth 
week and arises from the aorta at the level T12 - L2, a 
relationship that is constant between 24 and 44 weeks 
[Phelps et al 1972]. The renal artery divides into 
segmental arteries. These are end arteries, with no 
anastomoses between their branches at any level of 
division, rendering renal tissue in the region of their 
distribution vulnerable to ischemia following obstruction 
to flow. Further division gives rise in turn to interlobar, 
arcuate and interlobular arteries, from the last of which 
afferent arterioles lead to glomeruli. The glomerular 
capillary supply is connected to the peritubular 
capillaries by efferent arterioles. The venous drainage, 
unlike the arterial system, has anastomoses at several 
levels. The blood supply of the juxtamedullary nephrons 
differs from that of the outer cortical nephrons; the 
former have a network of vessels accompanying the loop of 
Henle to the tip of the medulla and then returning to 
the corticomedullary region, thereby allowing it to 
function as a countercurrent multiplier. 
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The morphological development of the kidney is 
accompanied by a changing distribution of intrarenal blood 
flow. In the immature puppy kidney, relative perfusion is 
highest in the juxtamedullary nephrons [Olbing et al 1973]. 
In the lamb, the intrauterine environment is also 
characterised by a relatively low renal blood flow and high 
renal vascular resistance [Aperia et al 1977; Robillard et 
al 1981 (i)]. The kidneys of fetal rhesus monkeys receive 
approximately 2.7% of the combined ventricular output 
[Behrman et al 1970]. Rudolf et al [1971], studying the 
circulation of the previable human fetus demonstrated a 
decrease in cardiac output to the kidneys, from a mean of 
6% in fetuses of under 50 g to around 3% in fetuses of over 
151 g. With the completion of nephrogenesis, there is a 
centrifugal redistribution of renal blood flow with 
decreased renal vascular resistance [Gruskin et al 1970]. 
Tubular function has begun by the ninth week and by 
the fourteenth week the loops of Henle are functioning. 
However even at term there is still an anatomical 
underdevelopment of the proximal tubules [Fetterman et al 
1965]. The largest, most mature juxtamedullary glomeruli 
possess the longest proximal tubules. During postnatal life 
the tubules lengthen, increasing absorptive and secretory 
capacity. 
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Kidney length increases from a mean of 31 mm at 24 
weeks gestation to 36 mm at 32 weeks and 41 mm at term 
[Jeanty et al 1982]. 
Little is known of the development of fetal renal 
sympathetic innervation. Although studies of the fetal lamb 
suggest that sympathetic function is not established till 
late in gestation [Assali et al 1962], Zimmerman [1972] 
describes innervation of the distal convoluted tubules 
in 13 -16 week gestation human fetuses. 
Intrauterine renal function 
Though the placenta is the major regulatory organ of 
the fetus and intact renal function is not necessary for 
fetal development, fetal renal function may influence fetal 
outcome. The most obvious example is the effect of 
reduced urine production on amniotic fluid volume and 
resultant fetal malformation; it is also probable that 
derangements in fetal regulation of extracellular fluid 
volume are responsible for some instances of poly and 
oligohydramnios. 
Urine production 
The human fetus begins urine production at around 
five weeks gestation. Kurjak et al [1981], using the 
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method devised by Campbell et al [1973], observed an 
increase in urine production from about 2 ml h-1 
(4.5 ml kg-1 h-1) at 20 weeks gestation to about 12 ml hr-1 
(6 ml kg - -1 hr -1) at 32 weeks and 26 ml h -1 at 39 weeks 
(8 ml kgf h1). Urine production then declines abruptly 
[Wladimiroff & Campbell 1974]. 
The factors regulating fetal urinary output in the 
human are poorly understood. The maternal administration 
of frusemide normally results in fetal diuresis. However 
the stressed fetus of an abnormal pregnancy may show no 
response to maternal frusemide and is more likely to have 
a lower urine production rate [ Wladimiroff & Campbell 1974] 
even when renal function is normal [Harman 1984] . This may 
be due to the increased level of antidiuretic hormone shown 
to occur in the stressed human infant at birth [De Vane & 
Porter 1980] and in the fetal lamb subjected to 
hypovolaemic [Kelly et al 1983] or asphyxial [De Vane et al 
1982] stress. Vasopressin is present in the human fetal 
pituitary by 11 -15 weeks gestation [Levina 1968;Schubert et 
al 1981]. 
There may be other hormonal influences on fetal 
urine production. Aldosterone affects electrolyte handling 
in the fetal lamb in a manner similar to the adult response 
[Siegel et al 1981]. However cortisol, while having little 
renal effect on the adult sheep kidney except at high 
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levels, results in increased fetal urinary flow and the 
increased excretion of sodium, potassium and chloride 
[Wintour et al 1985]. 
Between 34 - 40 weeks, the human fetus swallows 
between 200 and 600 ml of amniotic fluid daily [Gitlin et 
al 1972]. However there is no clear relationship between 
fetal urinary output, swallowing and amniotic fluid volume. 
Van Otterlo et al [1977], studying 67 normal pregnancies 
from 36 - 41 weeks gestation and 16 diabetic pregnancies 
between 28 - 40 weeks, found no relationship between the 
rate of fetal urine production and amniotic fluid volume. 
However a low urine flow rate was found with 
oligohydramnios with growth retardation of the fetus. 
Similarly, congenital malformations that prevent the 
ingestion of amniotic fluid are not invariably associated 
with polyhydramnios [Abramovitch et al 1979]. Wladimiroff 
and Campbell [1974] found no correlation between fetal 
weight and voiding rate. 
Though unecessary for intact development, the fetal 
kidney does respond appropriately to regulate water and 
electrolyte imbalance. Maternal polyhydramnios and 
neonatal hyponatraemia have been described in association 
with prolonged maternal ingestion of chlorothiazide 
[McCrory 1972]. It is likely that the fetal kidney 
responded to salt depletion by increasing urine output in 
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an attempt to correct the fetal sodium and water imbalance. 
In the chronically catheterised fetal sheep preparation, 
the maternal infusion of hypertonic saline has been shown 
to produce peaks in fetal vasopressin before and at peak 
fetal sodium concentration. This suggests that there was 
a rapid fetal to mother flow of water following maternal 
hypertonic saline administration and a combined 
volume -osmolar stimulus to the fetus [Leake et al 1977]. 
A strong correlation has been shown between maternal 
plasma volume and amniotic fluid volume when fetal 
malformations and diabetic pregnancies are excluded. The 
same authors [Goodlin et al 1983] also present evidence to 
suggest that fetal endocrine responses influence maternal 
plasma volume. 
Tubular function 
Gersh [1937] has studied the morphological 
differention of the thick and thin limbs of the loops of 
Henle in several animal species and correlated this 
with evidence of tubular function. On the basis of 
morphological criteria thus determined, he concluded that 
function was possible in human loops of Henle in the 
metanephros at thirteen weeks. 
Fetal urine is an ultrafiltrate of fetal serum and is 
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hypotonic throughout gestation, made so by selective 
reabsorption of sodium and chloride. A concentration of 
sodium in fetal urine exceeding 100 mmol-1 and osmolality 
exceeding 210 mosm kg-1 has been shown to be predictive of 
impaired renal function and poor fetal outcome [Golbus et 
al 1985]. The healthy fetus is thus capable of considerable 
retention of sodium, an obvious corollary to the demands of 
growth. 
The fetus at term also excretes a large amount of 
sodium, approximately 8 mmol kg-1 day-; this is of course in 
the face of an ad libitum intake via the placenta and is 
more than twice the amount such an infant is likely to 
receive from breast milk. The fetus must therefore have the 
capacity to increase tubular reabsorption of sodium 
still further, a response that comes into play following 
birth and the removal of transplacental supplies. 
The infant in utero is in a state of relative water 
diuresis, excreting around 20% of filtered water and 
forming urine with a low urea and creatinine urine to 
plasma ratio (approximately 5). There is virtually no 
phosphate or glucose in fetal urine, despite the fact that 
fetal serum has a higher concentration of inorganic 
phosphate than maternal serum [McCance & Widdowson 1953] 
demonstrating that these two discrete transport 
mechanisms are functional in the fetal kidney. 
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Glomerular filtration 
Glomerular filtration depends upon ultrafiltration 
pressure (the balance between hydrostatic pressure across 
the glomerular membrane and the osmotic pressure of non 
filtered colloids), renal plasma flow and the 
ultrafiltration coefficient (a function of total capillary 
surface area and permeability per unit area). The 
development of these factors during gestation has not been 
studied to any great extent in the human fetus. 
A mean glomerular filtration rate (GFR) of 2.66 ml 
min -1 (SD 1.47) has been estimated in term infants in utero 
in the six hours prior to delivery [Kurjak et al 1981] 
using ultrasound measurement of fetal urine production 
rate, cord blood creatinine and creatinine concentration in 
first voided urine. Other measurements of GFR have not been 
made in the human fetus in utero though attempts are being 
made to develop appropriate techniques [Glick et al 1985; 
Adzick et al 1985]. 
The results of animal studies cannot be extrapolated 
directly to the human fetus in view of variations in 
differentiation in relation to gestational age and the 
duration of intrauterine existence. An abrupt increase in 
GFR at the time of completion of nephrogenesis has been 
shown to occur in several mammalian species. The reasons 
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for this are not known. Until this point, although there 
is a steady increase in absolute GFR, GFR factored by 
weight remains relatively stable [Robillard et al 1975]. In 
chronically catheterised fetal lambs GFR increases at the 
same rate as body weight [Robillard et al 1975]. In the 
dog nephrogenesis is not completed until three weeks after 
birth; in the human nephrogenesis is completed at 34 
weeks gestation and GFR has been said to increase at this 
conceptional age [Arant 1978, Al- Dahhan et al 1983, Engle 
& Arant 1983] (see chapter 5 for further discussion). 
Hormonal regulation 
There are several hormonal systems influencing renal 
function during development; these include the 
renin- angiotensin- aldosterone system, kallikrein- kinin, 
the prostaglandins, vasopressin, vasotocin, the 
adrenergic system, corticosteroids and atrial natriuretic 
peptide. 
The human fetal kidney is able to produce renin from 
an early age. Juxtaglomerular cell granulation has been 
demonstrated at 15 weeks gestation [Molteni et al 1974]. 
Though renin does not cross the placenta [Symonds et al 
1968], either a low salt or a high potassium intake by the 
mother will induce hypersecretion of renin in the fetal 
lamb [Moore et al 1974]. Plasma renin activity and plasma 
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angiotensin II concentrations are higher in the fetus than 
in the mother [Broughton -Pipkin et al 1974]. Levels of 
these hormones increase following hypotension and hypoxia; 
in the fetal lamb model it has been shown that the 
renin -angiotensin -aldosterone has a greater role in 
modulating blood pressure and renal haemodynamics near 
term than early in gestation [Robillard & Nakamura 1988]. 
Exposure of the human fetus to angiotensin- converting- 
enzyme (ACE) inhibitors has been reported to cause 
oligohydramnios, neonatal renal failure and severe 
hypotension in addition to teratogenicity [Mehta & Modi 
1989]. 
The renal prostaglandins are modulators of renal 
vascular tone. Inhibition of prostaglandin synthesis by 
indomethacin causes an increase in renal vascular 
resistance [Matson et al 1981]. 
Vasopressin, or antidiuretic hormone, is present in 
the human fetal posterior pituitary by the 11th week of 
gestation [Levina 1968]. Vasopressin is believed to 
contribute to water homeostasis during fetal life. Both 
volume and osmoreceptor controls of vasopressin secretion 
are functional in the last trimester of gestation in the 
lamb fetus [Weitzman et al 1978]. Although the fetal 
nephron is believed to be less sensitive to vasopressin 
than the adult [Daniel et al 1982], the syndrome of 
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inappropriate antidiuretic hormone secretion does occur in 
extremely immature infants [Rees et al 1984]. 
Vasotocin is a neuropeptide that differs from 
vasopressin by a single amino acid substitution. Its role 
in the human fetus is not clear but in the lamb it is 
believed to be more important in the regulation of fetal 
sodium than fetal water [Ervin 1988]. 
The role of the sympathetic nervous system is largely 
unstudied in the human fetus. In the fetal lamb renal 
denervation does not affect renal haemodynamics [Robillard 
et al 1986] but stimulation of the renal nerves produces a 
fall in renal blood flow and rise in renal vascular 
resistance [Robillard et al 1987]. It is suggested that 
maturation of the renal adrenergic system is associated 
with a down regulation of beta adrenoceptors in renal 
vessels [Robillard et al 1988]. 
Atrial natriuretic peptide is produced in myocytes and 
has potent natriuretic and diuretic properties. Atrial 
natriuretic peptide may prove to be an important regulator 
of sodium homeostasis during perinatal life. Fetal levels 
are consistently higher than maternal [Yamaji et al 1986]. 
The fetus increases the cardiac content of atrial 
natriuretic peptide in response to intravascular volume 
expansion [Ross et al 1987]. 
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Cortisol has been shown to be natriuretic in the lamb 
fetus [Wintour et al 1985]. 
Perinatal homeostasis 
At birth the newborn kidney must abruptly assume 
control of fluid and electrolyte homeostasis. Total renal 
blood flow has been shown to increase during this period 
in the sheep [Nakamura et al 1987] and in canine puppies, 
the regional distribution of intrarenal blood flow 
changes; blood flow to the outer cortex increases while 
juxtamedullary blood flow remains unchanged [Jose et al 
1971] . 
The fetus in utero excretes a large volume of 
hypotonic urine of low sodium content. Following birth the 
infant enters a phase of relative oliguria. There is no 
evidence that GFR falls acutely in the first day following 
birth. GFR, when measured in the first day of life, 
correlates with gestational age when expressed in absolute 
terms (ml min -1) but shows if anything a tendency to fall 
when expressed factored for body weight (ml min -1 kg -1 
[Leake & Trygstad 1977]. This is similar to the pattern of 
development seen in the chronically catheterised sheep 
fetus [Robillard et al 1975], but is in marked contrast to 
the postnatal change in GFR when a rise occurs which is 
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disproportionately higher than the rise in body weight. 
The first urine formed postnatally is hypertonic to 
plasma with an increased concentration of urea, 
potassium and phosphate but not of sodium and chloride 
[McCance & Widdowson 1953].The change in urine volume thus 
appears to be brought about by a decrease in free water 
clearance. This may be mediated by the increased levels of 
arginine vasopressin (AVP) present in the neonate around 
delivery [Alexander et al 1980; Leung et al 1980]. 
The phase of relative oliguria is followed, after a 
variable period of hours to days, by a diuretic phase 
during which the extracellular space undergoes 
contraction. Sodium is the principal electrolyte of 
extracellular fluid and is of necessity lost during this 
contraction. In infants with respiratory disease the time 
of onset of diuresis is determined primarily by the 
onset of improvement in respiratory function. Though this 
association has been the subject of several investigations 
the underlying mechanisms have not been explained. Earlier 
suggestions that the diuresis represented an improvement in 
renal function consequent on improved oxygenation [Cort 
1962, Guignard et al 1976] were refuted when it was shown 
that the diuresis was not initiated subsequent to the 
improvement in respiratory function [Engle et al 1983, Heaf 
et al 1982, Langman et al 1981]. Certain authors [Engle et 
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al 1983, Heaf et al 1982, Langman et al 1981, Costarino et 
al 1985] have concluded that the diuresis precedes the 
improvement in respiratory function. However careful 
examination of their data reveals that they equally show 
that the onset of the diuretic phase in fact follows the 
onset of improvement in respiratory function and that 
continuing diuresis then accompanies continuing 
respiratory improvement. This subject is further discussed 
in chapter 8. 
There are maternal influences on neonatal fluid and 
electrolyte balance: an expanded extracellular volume has 
been described in preterm neonates whose mothers had 
received intravenous fluids prior to delivery [Rojas et al 
1984]; these infants, who were hyponatraemic, had an 
risk of developing pulmonary air leak, i.e. 
interstitial emphysema, pneumothorax, pneumomediastinum and 
pneumopericardium [Mohan et al 1984]. 
Despite certain functional limitations, the kidney in 
utero shows a sophisticated degree of maturation by the 
third trimester. Though the fetus is now known to play a 
role in modulating fluid flux between maternal, fetal 
and amniotic fluid compartments, these functions have 
neither been stressed nor have they been necessary for 
survival. Immediately following birth however, a remarkable 
series of pulmonary, cardiovascular and renal adaptations 
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are required to enable independent extrauterine survival. 
Neonatal renal function will be further discussed in the 




In this chapter, the basic methods utilised in this 
study as a whole, are described. Methodological details 
of specific relevance to individual aspects of the study 
are detailed in the appropriate chapters. 
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The Regional Neonatal Intensive Care Unit, Liverpool 
Maternity Hospital. 
The neonatal unit where this study was carried out is 
a tertiary referral centre admitting approximately 450 
babies each year. Approximately 30% are outborn and 
approximately 30% weigh less than 1500 g at birth. Primary 
neonatal surgical and cardiac case are not admitted. 
Standard methods of management for sick infants include 
monitoring of urine output using self adhesive bags, 
continuous or sequential measurement of blood pressure via 
a pressure transducer connected to an intra- arterial line 
or by peripheral oscillometry and measurement of arterial 
blood gases approximately 4 hourly. Blood pressure is 
maintained in line with the standards of Versmold et al 
[1981] using colloid transfusion or infusion of pressor 
agents. Frusemide and other diuretics are not used 
routinely. Ampicillin and gentamicin are first line 
antibiotics. The patency of umbilical arterial catheters is 
maintained by infusing 5% dextrose solution and of 
peripheral arterial catheters by infusing 0.45% saline. 
Heparin is a standard additive at a concentration of 1 unit 
per ml. Intravenous sodium supplementation is begun on the 
second day of life at 4 mmol kg -1 days. Infants are nursed 
under radiant warmers or in incubators. 
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Patients and study design 
Three groups of patients were studied. 
1. Renal function in the first week of life. 
Infants were selected for study from the admissions to 
the Regional Neonatal Intensive Care Unit, Liverpool 
Maternity Hospital. The study requirements were for male 
neonates, 34 weeks gestation and under, who had suffered no 
major perinatal asphyxia (1 minute Apgar greater than 3), 
who required ventilatory support and who required admission 
for the problems of immaturity. Infants with surgical 
problems, congenital infections and congenital 
abnormalities were not studied. It was only possible to 
study one infant at any time because of limited equipment. 
Continuous, sequential collections of urine in time 
blocks of approximately 4 hours each were made in these 
infants. Serial blood samples were obtained, consisting 
of 0.5 ml up to a maximum of 6 times a day and no more 
frequently than once every 4 hours. Urine sodium, 
creatinine, osmolality, glucose, chloride and potassium, 
plasma sodium, creatinine, osmolality, chloride and 
beta -2- microglobulin and blood glucose were measured. 
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The infants were weighed as often as possible, 
depending on clinical condition and upto a maximum of 
twice daily. A record was made of all intravenous and 
intraarterial fluids, including blood, blood products, 
flush fluids and drugs. The sodium content of fluid and 
drugs administered was recorded and in the case of blood 
and blood products, measured. Blood pressure and arterial 
blood gas measurements made 4 hourly were also recorded. 
Each 'period' was approximately 4 hours duration; 
however the precise duration was noted in minutes. Each 
day consisted of 6 'periods'; period 2 thus represented the 
second four hours of the first day of life; period 9 the 
third four hours of the second day; period 18 the last four 
hours of the third day and so on. 
The studies were begun as soon as possible after birth 
and were continued until leakage of urine from the 
collection system occurred. 
2. Serum beta -2- microglobulin 
Serum beta -2- microglobulin and serum creatinine were 
measured in infants of 34 weeks gestation and under, during 
the first three weeks of life. The infants were also 
selected from the admissions to the Regional Neonatal 
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Intensive Care Unit. They were male, healthy, breathing 
spontaneously in air, on full enteral feeds and receiving 
no antibiotic or diuretic therapy. Samples were obtained at 
the time of sampling for clinical purposes. further 
methodological details are to be found in chapter 10. 
3. Renal failure 
The incidence, aetiology and diagnostic 
characterization of acute renal failure, in a series of 388 
consecutive admissions to the Regional Neonatal Intensive 
Care Unit, were determined. Methodological details are 
described in chapter 11. 
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Methods and measurements 
Blood sampling 
Blood samples, of 0.5 ml volume, were obtained from 
heelpricks or indwelling arterial lines, at times 
coinciding with blood sampling for clinical purposes and 
upto a maximum of one sample during each 4 hour urine 
collection period. Samples were collected into lithium 
heparin tubes, spun immediately and the plasma separated 
and stored at -20 C prior to assay in batches. Samples 
for glucose assay were collected into fluoride oxalate 
tubes. 
Urine collection 
Urine was collected continuously using a closed circuit 
system consisting of a small plastic pouch applied to the 
baby's perineum with medical adhesive (Dow Corning) after 
the application of a skin protector. This pouch was 
connected, via two narrow plastic tubes, to a collection 
bottle and a low grade suction pump. Collection bottles 
were changed at approximately four hourly intervals; the 
precise duration of the four hourly collections was, 
however, also noted in minutes. The volume of urine in 
each collection bottle was measured and recorded and an 
aliquot stored frozen at -20C prior to assay in batches. 
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Laboratory methods 
All laboratory assays were performed by a single person 
(NR). Creatinine was measured in urine and plasma by the 
kinetic reaction rate Jaffe method using a Beckman 
analyser; sodium in plasma and urine and potassium in urine 
by flame photometry; glucose by the glucose oxidase method 
using a Beckman autoanalyser; osmolality by depression of 
freezing point; urea by the conductivity electrode urease 
method. Assay of serum beta -2- microglobulin was performed 
using the Enzygnost beta -2- microglobulin reagents from 
Behringwerke A.G., West Germany (supplied by Hoechst UK 
Ltd., Hounslow). 
Records 
A record was made of total fluid and sodium intake for 
each four hour period; this included the sodium content and 
volume of drugs, flush fluids and blood products. All drug 
administration was noted. Blood pressure measurements and 
arterial blood gas measurements made by the nursing and 
medical staff were recorded. 
Weight 
The babies were weighed once or twice daily, clinical 
condition permitting. All weighing was carried out by the 
investigator (NM). Electronic scales accurate to 2 g were 
used and weights were obtained net of intravenous lines, 
endotracheal tubes and other attachments. 
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Statistical analysis 
Statistical analysis was performed using the standard 
computer packages, SPSSX (Statistical Package for the 
Social Sciences; SPSS inc., 444 North Michegan Avenue, 
Chicago, Illinois 60611) and SAS (Statistical Analysis 
Systems), accessing the University of Liverpool IBM 3083. 
The statistical methods used were linear regression, 
multiple linear regression, one way analysis of variance, 
multiple comparison procedures, multivariate analysis of 
variance, paired and two sample T tests, the Mann Whitney 
U test and spline fitting routines. Further discussion of 
the statistical methods used are to be found in individual 
chapters. 
Presentation of data 
'Box and whisker' plots have been used for presentation of 
the raw data. Scatterplots, regression plots and spline 
fitted curves have been used for visual presentation of 
data following analysis. 
Numerical data relating to the sample studied have been 
presented as mean and standard deviation and median amd 




Creatinine clearance was calculated as creatinine excretion 
rate divided by plasma concentration. Excretion rates were 
calculated as the product of urine concentration and urine 
flow rate; filtered loads as the product of plasma 
concentration and creatinine clearance and fractional 
excretion as excretion rate divided by filtration rate. 
Osmolar clearance was calculated as osmolar excretion rate 
divided by plasma osmolality and free water clearance as 
urine flow rate minus osmolar clearance. Osmolar clearance 
is converted to ml for the calculation of free water 
clearance in the standard manner [Haycock 1987], that is, 
an osmolality of 280 mosm kg -1 is virtually 0.28 mosm m1-1. 
Tubular reabsorption of glucose is calculated as filtered 
glucose minus excreted glucose. Data are expressed per kg 
body weight. 
Standardisation of results 
Values have mainly been expressed in absolute terms and per 
unit weight. Where appropriate, values "corrected" for 
surface area have also been stated. In clinical practice 
expression of, for example, drug dosage, fluid allowances 
and electrolyte requirements, are standardised per unit 
body weight. The rationale of weight as the best 
standard is further discussed in chapter 5. Values 
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expressed per unit time are calculated per minute and if 
necessary standardised per hour or per day. 
Surface area 
The accurate measurement of height (length) in sick, low 
birth weight neonates is precluded by their clinical 
state. However the relationship of surface area to weight 
(W) during the perinatal period is represented by the self 
adjusting power equation [Boyd 1935]. 
.8168-0.015410gu 
S = 4.688W0 
The standard deviation of the percentage deviation of 
calculated surface areas and 'true' measured surface areas 
using this equation is 7.8 +- 0.4 %. The difference of 
0.7% from the standard deviation of 7.1 +- 0.3% using the 
height (H)- weight self adjusting power equation, 
S = 3.207W0.7285-0.01881ogYx03 
is so small as to be of little practical benefit [Boyd 
1935; Brody et al 1928]. The self adjusting power equation 
incorporating weight alone has therefore been used for all 
estimates of surface area. 
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Data handling 
Descriptive and numerical data for each infant were entered 
into a data file in free format on the mainframe Liverpool 
IBM 3083. Thirty two variables were entered into each line 
of data. Each line represented one period (approximately 4 
hours) of urine collection for an individual baby. For 
example the data sequence 
441193 28 1.2 1 0 4 3 5 250 5 3.5 89 1140 260 6.5 140 78 
280 6.5 440 38 1.250 1 3.1 0.12 11.8 6 66 10.4 118 0.3 
represented the following: identification number, 
gestational age, birth weight, maternal pre -eclampsia 
(no =0, yes =1), maternal antepartum haemorrhage (no =0, 
yes =1), one minute apgar score, day of life, period of day, 
duration in minutes of period, volume of fluid intake 
during this period (see explanation above), urinary output, 
urinary sodium, urinary creatinine, urinary osmolality, 
urinary glucose, plasma sodium, plasma creatinine, plasma 
osmolality, blood glucose, alveolar arterial oxygen 
gradient, mean blood pressure, present weight, 
pancuronium used (no =0, yes =1), serum 
beta -2- microglobulin, surface area, urinary urea, urinary 
potassium, urinary chloride, plasma urea, plasma 
chloride, sodium intake. Missing values were noted as -1. 
43 
Ethical approval 
This study had the approval of the local ethical committee. 
Every attempt was made to discuss this study with the 
baby's parents though, as some infants were postnatal 
transfers, this was not always possible. Written consent 
was not obtained as the study did not alter or impinge on 
clinical management in any way and as blood samples were 
obtained at times of clinical sampling from indwelling 
lines. 
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Abbreviations and units 
SI units are used throughout. 





















free water clearance 
fractional sodium excretion 
fractional urine flow 
ml min -1 
ml min-1 kg -1 




ml min -1 kg 
-1 
% 
partial pressure of alveolar oxygen 
partial pressure of arterial oxygen 
partial pressure of arterial carbon dioxide 
alveolar arterial oxygen gradient 
urinary creatinine 
plasma creatinine 









UK urinary potassium 
SB2MG serum beta- 2- micoglobulin 
Fi02 fractional inspired oxygen 
GFR glomerular filtration rate 
ANP atrial natriuretic peptide 
AVP arginine vasopressin 
RFI renal failure index 
ARF acute renal failure 



















CCr = UCr. V/PCr 
COsm = UOsm. V/POsm 
CH2O = V - COsm 
FeNa = UNa/PNa. PCr/UCr.100 
FeUV = PCr/UCr.100 






RFI = UNa. PCr/UCr 




This chapter begins with a brief clinical account of 
the babies studied. In each case the clinical description 
is followed by a summary measure of the daily 4 hourly 
measurements of fluid and sodium intakes, urine output, 
weight change in relation to birth weight, sodium balance, 
mean daily plasma sodium and osmolality and mean daily 
alveolar -arterial oxygen difference. Specific points are 
made after each clinical description. 'Box and whisker' 
plots are then used to summarise mean daily fluid intake, 
plasma sodium and plasma osmolality for all the babies 
studied. The chapter concludes with a general commentary 
on the observations made. Further specific points are 
discussed in subsequent chapters. 
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Units of expression. 
fluid intake ml kg -1 day-1 
urine flow rate ml kg -1 hour-1 
sodium intake mmol kg-1 day-1 
sodium balance mmol kg-1 day1 







mmol 1 -1 
mosm 1 -1 
mmol 1-1 
torr 
For explanation of abbreviations see p 45. Please note that 
a negative weight change implies weight gain (p 46). 
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Baby: 1 
Gestational age: 28 weeks 
Birth weight: 1.24 kg 
The first of twins born by emergency caesarian section 
following antepartum haemorrhage and fetal bradycardia. 
Received fresh frozen plasma at birth for hypotension. 
Ventilated for 3 days. Normal at 4 year follow up. 
day 
fluid intake 






















Gestational age: 26 weeks 
Birth weight: 1.008 kg 
The second of twins born by vaginal vertex delivery 
following spontaneous onset of labour. In good condition at 
birth. Ventilated for 25 days; developed chronic lung 
disease with an additional oxygen requirement to day 50. 
Ventriculoperitoneal shunt inserted for posthaemorrhagic 
hydrocephalus. At 5 year follow up normal gross motor 
development but deaf with poor speech. 
Note large sodium loss from day 2 and 27.2% weight loss by 
day 5. 
day 2 
fluid intake 136 
urine flow rate 3.8 
sodium intake 4.9 
sodium balance -4.7 
weight change 10.1 
mean posm 295 
mean pna 139 
mean uosm 511 
mean una 106 
mean AaDO2 316 
3 4 5 6 7 
106 132 152 158 175 
3.0 5.4 3.7 5.1 3.4 
3.1 3.7 5.7 4.8 5.3 
-7.0 -13.7 -6.1 -6.6 -4.3 
14.5 21.5 27.2 26.3 26.4 
298 292 300 309 
143 140 140 140 123 
520 409 367 305 395 
138 131 129 95 120 
323 272 190 157 51 
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Baby: 3 
Gestational age: 32 weeks 
Birth weight: 1.5 kg 
The first of twins born in good condition by spontaneous 
vertex delivery. Ventilated from birth with an 
uncomplicated early course. Requiring CPAP alone by day 5. 
Deteriorated on day 7 with the onset of E. coli septicaemia 
complicated by disseminated intravascular coagulation and 
acute renal failure managed with peritoneal dialysis. Died 
on day 18. 
Note the positive sodium balance on day 2 followed by 
negative balance on day 3 in association with improving 
respiratory function despite the similarity of sodium 
intakes and urine outputs 
day 
fluid intake 









on days 2 
2 3 
and 3. 
4 5 6 
99 101 143 181 148 
3.3 2.7 6.3 3.0 5.3 
3.0 3.1 4.2 7.3 4.3 
1.0 -0.6 -3.5 3.0 0.4 
-2.8 -0.7 -0.7 5.6 1.0 
289 304 299 287 311 
139 144 141 143 146 
432 562 401 264 174 
26 59 57 58 27 
326 179 75 39 40 
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Baby: 4 
Gestational age: 27 weeks 
Birth weight: 1.060 
Vaginal vertex delivery following spontaneous onset of 
labour. In good condition at birth. No ventilation 
required. Died on day 8 following klebsiella septicaemia. 
Note hypernatraemic dehydration with 13.8 % weight loss by 


























Gestational age: 32 weeks 
Birth weight: 1.618 kg 
Born by emergency caesarian section for preeclamptic 
toxaemia. In good condition at birth. Ventilated for 6 
days. Normal at 5 year follow up. 
Note good urine output from day 1, early positive sodium 
balance and low urine sodium concentration. 
day 1 
fluid intake 76 
urine flow rate 1.5 
sodium intake 0.5 
sodium balance 
weight change 
mean posm 304 
mean pna 132 
mean uosm 
mean una 
mean AaDO2 596 
2 3 4 5 
73 92 100 119 
2.0 2.3 3.1 2.9 
1.5 2.5 3.0 3.6 
0.7 0.9 -1.8 1.5 
3.8 4.9 
296 299 322 297 
141 140 141 142 
221 216 218 104 
16 40 74 28 
599 543 514 472 
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Baby: 6 
Gestational age: 30 weeks 
Birth weight: 1.490 kg 
Spontaneous vertex delivery. Apgar score of 10 at 1 minute. 
Ventilated for 3 hours. Normal at 4 year follow up. 
Note low sodium intake, negative sodium balance and low 
urinary sodium concentration on day 1. 
day 
fluid intake 









1 2 3 4 
77 79 77 63 
1.3 2.5 2.7 1.9 
0.3 1.4 2.3 2.0 
-0.3 -1.2 -4.2 -3.7 
2.8 4.3 12.2 16.4 
283 290 312 
138 131 148 
209 206 313 411 




Gestational age: 34 weeks 
Birth weight: 1.632 kg 
Delivered by emergency caesarian section for fetal distress 
following death of twin. Apgar score of 9 at 1 minute. 
Normal at 5 year follow up. 
Note inability to 
day 
fluid intake 













72 81 92 90 
1.1 3.8 2.8 2.4 
0.3 0.4 0.8 0.2 
0 -4.0 -6.0 -2.1 
0.3 4.5 5.2 6.9 
293 291 292 
142 145 143 
230 242 307 225 




Gestational age: 29 weeks 
Birth weight: 1.488 kg 
The second of twins delivered vaginally. Bruised at birth. 













1 2 3 
81 79 67 
0.7 2.7 2.6 
4.4 2.6 2.2 
3.6 -2.3 -2.6 
-0.4 -1.3 3.0 
301 310 301 
139 144 138 
296 355 416 
44 74 80 
584 578 485 
56 
Baby: 9 
Gestational age: 29 weeks 
Birth weight: 1.0 kg 
Vaginal breech delivery following spontaneous rupture of 
membranes 5 days previously. Bruised at birth and received 
transfusion of blood and fresh frozen plasma. Ventilated 
for 5 days. Developed pulmonary interstitial emphysema. 
Poor urine output for 4 days. Discharged home but lost to 
follow up. 
Note mean urine osmolality on day 1 of 708 mosm 1 -1. 
day 1 2 3 4 
fluid intake 









120 65 74 89 
0.3 0.6 0.8 0.8 
6.5 2.6 2.7 5.4 
5.8 0.6 1.1 4.2 
-9.0 -10.0 -9.6 -12.6 
308 310 311 307 
146 137 145 141 
708 547 523 544 
115 127 83 63 
449 406 421 311 
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Baby: 10 
Gestational age: 31 weeks 
Birth weight: 1.62 
Delivered by emergency caesarian section for fetal 
bradycardia following antepartum haemorrhage. Received 
sodium bicarbonate on day 1. Ventilated for 7 days. 
S. aureus septicaemia on day 2. Normal at 5 year follow up. 
day 
fluid intake 

































Gestational age: 27 weeks 
Birth weight: 1.12 kg 
Precipitous vaginal vertex delivery. Ventilated 
uneventfully from birth. Developed posthaemorrhagic 
hydrocephalus. Died on day 16 of necrotising enterocolitis. 
Note 21.2 % weight 
day 
fluid intake 























Gestational age: 27 weeks 
Birth weight: 0.780 kg 
Delivered by emergency caesarian section for preeclampsia. 
Metabolic acidosis on day 2 treated with sodium 
bicarbonate. Ventilatory support discontinued at 11 days 
following major periventricular haemorrhage and anuria. 
day 
fluid intake 









2 3 4 5 6 
92 143 115 152 176 
0.5 1.6 2.9 4.6 2.6 
4.8 12.3 5.6 7.7 6.8 
4.2 9.2 -1.9 -5.1 -1.1 
6.8 6.9 
290 302 301 297 272 
139 144 143 139 137 
390 357 335 334 370 
66 77 106 119 127 
560 576 516 529 572 
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Baby: 13 
Gestational age: 30 weeks 
Birth weight: 1.482 
Vaginal vertex delivery following antepartum haemorrhage. 


























Gestational age: 30 weeks 
Birth weight: 1.12 kg 
In good condition following vaginal breech delivery. 
Ventilated uneventfully for 3 days. Lost to follow up. 
day 
fluid intake 






















Gestational age: 28 weeks 
Birth weight: 1.222 kg 
Delivered by emergency caesarian section following 
spontaneous onset of preterm labour. Bruised at delivery 
but otherwise in good condition. Ventilated for 5 days. 
Normal at 5 year follow up. 













1 2 3 4 
59 79 84 97 
0.2 0.7 3.8 1.7 
1.5 5.7 1.9 4.7 
1.3 5.0 -3.3 -0.1 
-2.6 -5.1 -0.2 
262 275 283 277 
128 128 140 135 
332 419 306 318 
41 44 55 120 
602 601 341 44 
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Baby: 16 
Gestational age: 25 weeks 
Birth weight: 0.680 kg 
Vaginal vertex delivery following placental abruption. 
Developed severe respiratory disease. Subsequent chronic 
lung disease complicated by transfusion acquired 













1 2 3 
124 101 119 
0.4 0.9 1.5 
5.1 3.8 2.4 
4.6 1.7 -0.2 
0 1.5 0.7 
282 300 308 
136 147 147 
501 518 426 
59 99 67 
610 610 620 
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Baby: 17 
Gestational age: 25 weeks 
Birth weight: 0.800 kg 
Vaginal vertex delivery. Developed severe respiratory 
disease. Received sodium bicarbonate and colloid on day 1. 
Hyperkalaemia at 24 hours treated sucessfully with dextrose 
and insulin. Died at 48 hours of respiratory failure. 
Note the similarity of plasma and urine sodium 
concentrations in this profoundly hypernatraemic baby. 
day 
fluid intake 





















Gestational age: 26 weeks 
Birth weight: 1.002 kg 
Delivered by caesarian section for preterm labour. Bruised 
at birth. Developed chronic lung disease and required 
ventilation for 50 days. Ventriculoperitoneal shunt 
inserted for posthaemorrhagic hydrocephalus. Borderline 
normal at 4 year follow up. 
Note hypernatraemic dehydration with almost 20 % weight 













1 2 3 4 
82 98 104 90 
0.24 2.5 4.1 3.6 
1.9 3.7 5.5 3.1 
1.6 -2.1 -9.0 -9.8 
0 4 19.6 
289 312 300 313 
136 143 142 149 
467 335 409 435 
60 90 145 147 
423 269 214 222 
66 
Baby: 19 
Gestational age: 31 weeks 
Birth weight: 1.374 kg 
Delivered by emergency caesarian section for fetal distress 
and antepartum haemorrhage. Ventilated for 4 days. Normal 
at 4 year follow up. 
day 
fluid intake 









1 2 3 
72 96 115 
1.9 3.4 3.9 
1.1 3.1 3.5 
-1.9 -4.2 -7.7 
2.6 10.3 12.1 
282 299 271 
138 141 139 
247 291 321 
73 100 124 
284 314 222 
67 
Baby: 20 
Gestational age: 32 weeks 
Birth weight: 1.832 kg 
Vertex vaginal delivery following spontaneous onset of 
labour. In good condition at birth. Required head box 
oxygen for 24 hours but no ventilatory support. 
day 1 2 
fluid intake 48 73 
urine flow rate 0.5 2.1 
sodium intake 0.5 0.6 
sodium balance 0 0 
weight change 1.0 2.8 
mean posen 269 279 
mean pna 136 137 
mean uosm 340 177 
mean una 42 13 
mean AaDO2 45 40 
68 
Baby: 21 
Gestational age: 28 weeks 
Birth weight: 1.022 kg 
Vaginal breech delivery. Bruised at birth. Ventilated for 
4 days. Developed post haemorrhagic ventricular dilatation. 
Exchange transfusion for jaundice carried out on day 7 but 
died the following day of kernicterus. 
Note inability to maintain urinary sodium loss on day 2 
day 1 
fluid intake 100 
urine flow rate 0.7 
sodium intake 0.9 
sodium balance -0.6 
weight change 
mean posm 297 
mean pna 142 
mean uosm 271 
mean una 76 













Gestational age: 29 weeks 
Birth weight: 0.988 kg 
Delivered by emergency caesarian section for preeclamptic 
toxaemia. Developed chronic lung disease and required 
ventilation for 50 days. Died of respiratory failure 
precipitated by pneumonia at the age of 5 months. 
day 
fluid intake 









2 3 4 5 
97 90 93 105 
2.6 3.3 3.3 3.8 
3.3 4.3 3.2 6.5 
-0.2 -6.5 -7.3 -2.5 
0.3 4.8 8.8 
298 281 
138 141 135 
228 343 345 242 
56 134 133 99 
521 583 488 342 
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Baby: 23 
Gestational age: 28 weeks 
Birth weight: 1.082 kg 
Delivered by emergency caesarian section for fetal 
distress. Ventilated for 8 days. Developed enterobacter 
cloacae septicaemia on day 12 leading to death on day 18. 


























Gestational age: 30 weeks 
Birth weight: 1.480 kg 
Delivered by emergency caesarian section for maternal 
preeclampsia and pyrexia. Ventilated for 5 days. Fluids 
restricted because of early oliguria and oedema. Discharged 
home but lost to follow up. 
Note very low urine 
day 
fluid intake 









sodium concentration on day 2. 
2 3 4 5 
53 39 75 79 
0.1 2.4 4.8 1.6 
1.3 1.8 4.2 2.6 
1.2 -4.0 -8.1 -2.8 
-3.9 -1.9 5.9 9.7 
282 256 282 
135 135 136 138 
355 387 369 425 
29 71 116 142 
474 211 84 40 
72 
Baby: 25 
Gestational age: 25 weeks 
Birth weight: 0.868 kg 
Vaginal breech delivery. Developed chronic lung disease 
with ventilator dependence. Died on day 48 of serratia 
septicaemia. 
Note relatively high early urine osmolality. 
day 
fluid intake 









1 2 3 
120 129 104 
0.1 0.5 2.1 
2.9 4.2 4.5 
2.7 2.6 -2.6 
0 1.4 3.2 
293 299 
134 142 
519 598 443 
128 130 143 
513 346 197 
73 
Baby: 26 
Gestational age: 32 weeks 
Birth weight: 1.46 kg 
Born at home following concealed pregnancy and antepartum 
haemorrhage. On admission hypothermic and hypovolaemic from 
cord haemorrhage. Ventilated to day 32; pneumothoraces on 
days 2 and 3. Developed unilateral periventricular 
leukomalacia and post haemorrhagic hydrocephalus; 
ventriculoperitoneal shunt inserted; subsequent 
s.epidermidis septicaemia and ventriculitis. Spastic 
diplegia at 4 year follow up. 
Note urine output in excess of 1 ml kg-1 hour -1 from day 1 
and early positive sodium balance. 
day 1 
fluid in 90 
urine flow 1.2 
sodium in 5.4 
sodium bal 
wt change 0 
mean posm 
mean pna 138 
mean uosm 
mean una 
mean AaDO2 504 
2 3 4 5 6 7 
108 77 88 66 73 77 
1.4 1.7 1.9 1.7 0.6 1.4 
7.4 3.4 3.5 3.0 6.2 7.7 
6.1 -0.5 0.1 -1.0 5.9 6.3 
-6.7 -7.8 -7.1 -8.5 
138 137 137 140 137 139 
361 345 450 408 438 422 
40 98 75 97 24 43 
514 617 621 603 609 544 
74 
Baby: 27 
Gestational age: 28 weeks 
Birth weight: 0.906 kg 
Emergency caesarian section for pre -eclampsia and essential 
hypertension. Ventilated for 10 days. Ventriculoperitoneal 
shunt inserted on day 46 for post haemorrhagic 
hydrocephalus. Left hemiplegia and right retinopathy of 
prematurity at 3 year follow up. 
day 
fluid intake 









2 3 4 5 6 
131 88 109 104 129 
0.8 1.4 2.6 3.1 4.4 
5.2 4.7 6.2 6.2 5.5 
4.2 1.2 -0.6 -2.0 -7.4 
-0.6 -3.1 -1.1 1.3 3.3 
273 270 286 257 296 
137 138 142 146 147 
283 404 307 356 383 
65 97 108 116 124 
583 574 536 540 194 
75 
Baby: 28 
Gestational age: 26 weeks 
Birth weight: 0.884 kg 
Spontaneous onset of labour following premature rupture of 
membranes after late amniocentesis for high alphafeto 
protein. Vaginal vertex delivery. Developed severe 
respiratory distress syndrome and chronic lung disease. 















septicaemia and meningitis. 
3 4 5 6 7 
136 129 110 90 112 107 120 
1.0 0.9 0.6 2.2 2.8 3.1 3.4 
7.8 9.6 5.1 2.5 6.0 3.7 4.0 
5.5 8.1 4.4 -2.3 4.6 1.8 
0 0.2 -1.2 1.1 4.1 11.3 
274 298 304 295 313 298 308 
139 145 139 140 140 137 142 
370 377 355 426 434 390 
95 97 54 106 102 126 
547 614 596 587 495 458 267 
76 
Baby: 29 
Gestational age: 29 weeks 
Birth weight: 1.260 kg 
Delivered by emergency caesarian section following 
spontaneous rupture of membranes and antepartum haemorrhage 
to a 31 year old mother on holiday from South Africa. 
Developed severe respiratory distress syndrome and chronic 
lung disease requiring ventilation to day 19 and additional 
oxygen to day 41. No follow up. 
Note relatively high early urine osmolality. 
day 1 2 
fluid in 111 65 
urine flow 0.6 0.7 
sodium in 5.2 2.9 
sodium bal 3.7 1.8 
wt change -1.6 -4.1 
mean posm 262 292 
mean pna 135 132 
mean uosm 537 555 
mean una 93 82 
mean AaDO2 610 582 
3 4 5 6 7 
71 54 82 89 104 
2.5 1.5 2.2 2.1 1.0 
5.6 1.6 0.3 2.4 6.6 
-3.4 -3.5 -6.4 -3.2 5.2 
-0.4 7.9 16 18.4 14.6 
286 290 290 307 299 
136 144 142 138 143 
367 458 347 427 641 
144 129 127 105 57 
582 384 370 256 242 
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Baby: 30 
Gestational age: 30 weeks 
Birth weight: 1.004 kg 
Born by emergency caesarian section for fetal distress and 
pre -eclampsia. In good condition at birth. Ventilated to 
day 8 and in air by day 9. Normal at 4 year follow up. 
day 
fluid intake 






















Gestational age: 26 weeks 
Birth weight: 0.766 kg 
Vaginal vertex delivery following spontaneous rupture of 
membranes. Extensive bruising at birth. Mother pyrexial and 
baby neutropenic but no organisms isolated. Early anuria. 
Ventilated to day 40; in additional oxygen to day 56. 
Developed post haemorrhagic hydrocephalus; 
ventriculoperitoneal shunt inserted. Myopic with left 
hemiplegia at 4 year follow up. 
Note early and persistent weight gain and high urine 
osmolality on day 1. 
day 2 
fluid intake 80 
urine flow rate 0.02 
sodium intake 4.6 
sodium balance 4.5 
weight change -19.1 
mean posen 302 
mean pna 138 
mean uosm 715 
mean una 138 
mean AaDO2 235 
3 4 5 6 7 
70 170 162 132 118 
1.8 1.0 1.3 2.6 3.0 
2.4 1.9 2.5 4.5 3.9 
-4.7 -0.4 0 -0.7 -3.1 
-6.1 -6.0 -7.4 
338 322 284 277 
153 150 130 122 
495 444 400 370 313 
177 114 66 81 86 
465 425 466 864 411 
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Baby: 32 
Gestational age: 25 weeks 
Birth weight: 0.824 kg 
Vaginal vertex delivery following spontaneous onset of 
labour. Bruised at birth. Found to have a large posterior 
fossa haemorrhage; developed severe lung disease. Died on 
day 1. 
Note extremely large sodium intake resulting from intensive 
resuscitation. 
day 1 
fluid intake 187 
urine flow rate 1.2 
sodium intake 24.5 
sodium balance 19.8 
weight change 0.4 
mean posm 304 
mean pna 141 
mean uosm 366 
mean una 164 
mean AaDO2 599 
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Baby: 33 
Gestational age: 27 weeks 
Birth weight: 1.16 kg 
The second of twins born by emergency caesarian section 
following maternal antepartum haemorrhage. Badly bruised at 
delivery. Ventilated for 9 days. Developed bilateral grade 
III periventricular haemorrhage on day 2; associated 
convulsions and metabolic acidosis treated with 
phenobarbitone and sodium bicarbonate. At 4 year follow up, 
myopic with motor clumsiness and cognitive delay. 
Note large sodium intake on day 2 due to sodium bicarbonate 
administration and high urine osmolality on day 1. 
day 1 2 3 
fluid intake 95 126 123 
urine flow rate 0.2 1.6 2.1 
sodium intake 2.4 9.1 5.7 
sodium balance 2.1 5.5 -1.9 
weight change 0.8 0.9 7.1 
mean posen 281 295 296 
mean pna 136 137 137 
mean uosm 739 398 531 
mean una 71 104 167 
mean AaDO2 92 104 107 
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Baby: 34 
Gestational age: 28 weeks 
Birth weight: 1.332 kg 
The second of monozygotic twins born by emergency caesarian 
section in view of a bradycardia in twin I. Apgar score of 
9 at 1 minute. Maternal rhesus isoimmunisation but no 
consequent neonatal problems. Ventilated for 2 days, in air 
by day 8. Normal at 4 year follow up. 
Note 15.6 % weight loss on day 3 associated with 
hypernatraemia but no increase in urine osmolality. 
day 1 2 3 
fluid intake 









82 99 132 
1.3 2.5 5.8 
0.7 1.3 4.0 
-1.2 -2.6 -6.3 
3.6 11.6 15.6 
285 288 292 
141 148 149 
226 239 221 
62 68 74 
167 99 120 
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Figure 4.1 
Fluid intake (ml kg -1 day1) by postnatal age. 
Box and whisker plot showing medians, interquartile range 













Plasma sodium (mmol l-1) by postnatal age. 
Box and whisker plot showing medians, interquartile range 
and extreme values. 
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Figure 4.3 
Plasma osmolality (mosm 1 -1) by postnatal age. 
Box and whisker plot showing medians, interquartile range 




The standard policy in this neonatal unit during the 
study period was, as in most others, to commence with a 
fluid intake of 60 ml kg-1 day-, increasing to 90, 120 and 
150 ml kg -1 with alterations as clinically indicated. 
Infants nursed under radiant warmers were prescribed an 
increase of 30 ml kg-1. Observation of actual fluid intakes 
showed that the infants rarely received this regime. A 
variable water requirement is understandable given the very 
variable insensible water losses. Infants might be nursed 
under radiant warmers, in incubators and under a variety of 
coverings such as bubble wrap, polythene sheeting or 
perspex shields all of which would influence transcutaneous 
losses and add to the inherant variation between babies. 
The 60 -90- 120 -150 formula, so widely used and incorporated 
into teaching lore, is probably not appropriate for the 
neonatal intensive care setting. Probably a better 
guideline would be to suggest a starting volume based on 
estimated insensible water losses and one and a half times 
the minimum urine output of 30 ml kg -1 day -1. Adjustments 
should then be made every 6 -8 hours based on urine output, 
clinical condition and serum electrolytes. 
Urine flow rate was very often less than 1 ml kg1 h -1 
on the first day of life. It is unclear whether this 
reflected a transient period of renal impairment or normal 
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first day physiology. Healthy babies are known to be 
relatively oliguric immediately following birth. This is 
further discussed in subsequent chapters. 
True sodium intake varied considerably. Despite a unit 
policy to begin with 4 mmol kg-1 day-1 on the second day of 
life, every baby received some sodium from the first day 
and many received appreciable amounts. Positive sodium 
balance was frequently seen on the first day of life and 
many babies failed to show the expected early weight loss 
and indeed showed an inappropriate weight gain. Daily 
weight loss should be of the order of 1% in such babies. 
Hypernatraemia occurred in 11 babies in conjunction 
with weight loss and was due to dehydration. Hypernatraemia 
in association with weight gain was seen in only two babies 
(9 and 31). Inappropriate weight gain occurred frequently 
together with a normal plasma sodium and this suggested 
expansion of the extracellular space. These babies appeared 
to have been given too much sodium. The babies obviously 
retained too much water but they do not appear to have been 
given too much water. Certainly hyponatraemia was uncommon; 
it occurred in baby 15 in association with weight gain and 
in baby 2 in association with weight loss. 
The babies were also generally hyperosmolar; this 
would have resulted in a stimulus to vasopressin secretion 
87 
which in turn could explain a poor urine output. It is 
possible therefore that an explanation for the 
abnormalities seen is that the babies received too much 
sodium and normal to low amounts of water resulting in avid 
water retention and a poor urine output. 
It is immediately apparent that the administration of 
sodium bicarbonate results in a large sodium intake as a 
4.2% solution contains 0.5 ml sodium m1 -1. However 
appreciable inapparent intakes sometimes resulted from the 
normal saline used to flush lines. The use of normal saline 
to maintain patency of peripheral or umbilical lines as 
opposed to dextrose for an umbilical line and 0.45% saline 
for peripheral arterial lines was another contributory 
factor. 
Urine sodium concentration and osmolality considered 
alone were unlikely to assist clinical management. Urinary 
sodium concentrations were almost invariably high, 
exceeding 50 mmol 1 -1; any decision based on this parameter 
alone to increase sodium intake would have been 
questionable given the frequence concurrence of 
inappropriate positive sodium balance. Baby 24 had an 
unusually low mean urinary sodium concentration of 29 mmol 
1-1 on day 2 with positive sodium balance and weight gain; 
a decision to increase sodium intake solely on the basis of 
this information would again have been inappropriate. 
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Urine osmolality lay most often between 200 - 450 
mosm 1 -1 and seemed to be a poor reflection of hydration. 
Eleven babies developed hypernatraemic dehydration and 
during these episodes mean urine osmolality ranged from 174 
- 518 mosm 1 -1. 
What improvements might be made to fluid and 
electrolyte management in the newborn baby? In terms of 
clinical practice four suggestions should be made: we 
require the means to accurately and easily monitor urine 
output; to accurately weigh sick infants without 
disturbance; the clinical resolve to ensure that sodium and 
water are prescribed independently and the ability to 
rapidly and precisely calculate true water and electrolyte 
intakes inclusive of all sources. This last could easily be 
computed at the cotside using a programmable hand held 
calculator. 
These observations are discussed in detail in the 
chapters which follow. 
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5 
GLOMERULAR FILTRATION RATE 
The value of glomerular filtration rate (GFR) as an 
index of renal function is sometimes controversial, but it 
remains an accepted standard. Several studies have been 
made of GFR in neonates but these have, on the whole, been 
confined to 'healthy' infants not requiring ventilatory 
support or intravenous fluids. The rationale for this 
approach is understandable. Nevertheless, it has resulted 
in an inevitable paucity of data pertaining to the typical 
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immature infant to be found in intensive care units. In 
addition, where utilised, urine collections have often been 
of short duration and measurements expressed as absolute 
values or 'corrected' for surface area; raw data has 
generally not been published. The aim of this section of 
the study was to determine GFR as endogenous creatinine 
clearance during the first week of life in a typical 
population of preterm infants requiring intensive care and 
to compare these measurements with published data relating 
to 'well' preterm neonates. 
The measurement of glomerular filtration rate 
Inulin clearance remains the 'gold standard' for the 
measurement of GFR. Coulthard (1983) has studied several 
methods of measuring GFR in the neonate, using inulin. 
Given the slower equilibration period of substances 
handled by the newborn kidney he found two methods 
reliable; a constant infusion technique over 24 hours or a 
single injection method with sampling over 5 hours 
combined with urine collection. Both methods are difficult 
to perform, especially in the preterm neonate receiving 
intensive care. 
Coulthard et al [1985] found agreement between inulin 
clearance and 'true' creatinine clearance. 'True' 
creatinine was measured following adsorption onto Dowex -50 
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resin - a method that is laborious and unsuited to routine 
use. Under ideal circumstances the preferred method would 
be measurement using high pressure liquid chromatography 
(HPLC) or dilution mass spectroscopy but these 
methodologies are not readiliy available. In clinical 
practice today creatinine is usually measured following its 
reaction with alkaline picrate. However other chromogens in 
plasma also react with alkaline picrate falsely elevating 
levels. Automated methods have therefore been developed 
which use reaction rate analysis - measuring the generation 
of colour during incubation with picrate. Such methods 
reduce [Coulthard et al 1985] and may eliminate [Arant 
1978] interference from non -creatinine chromogens. Though 
there is thus a possibility of overestimating plasma 
creatinine, on the whole correlation is good [Stonestreet 
et al 1979]. As the purpose of the present study was to 
obtain data of use in everyday clinical practice, 
measurement of plasma creatinine was made with the widely 
available Beckman autoanalyser which utilises the kinetic 
reaction rate Jaffe method and which was in standard 
clinical use at the time of this study. Plasma creatinine 
measured by Beckman autoanalyser shows minimal positive 




Glomerular filtration rate, as endogenous creatinine 
clearance, was measured during the first week of life in 
the study population described in chapter 3. Calculations 
were only performed when the urine flow rate equalled or 
exceeded 0.5 ml kg -1 h-1 so as to minimise the chances of 
including data from infants with unrecognised renal 
impairment. 
Absolute daily GFR was calculated for each baby as the 
product of mean daily urinary creatinine and total daily 
urine output divided by the product of mean daily serum 
creatinine and total duration of daily urine collection. 
Absolute GFR was also calculated for each baby 
individually as the product of mean urinary creatinine for 
the whole collection period and total urine output divided 
by the product of mean serum creatinine and total duration 
of urine collection in minutes. 
GFR expressed per kilogram was calculated using 
birthweight, as opposed to actual weight on the day of 
study. The rationale for this is discussed below. Surface 
area (SA) was estimated from birthweight (BW) using 
Boyd's self -adjusting power equation [Boyd 1935] as 
described in chapter 3 - Methods. 
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Statistical analyses were by linear regression, 
one -way analysis of variance, multivariate analysis of 
variance and multiple comparison procedures. 
Results 
Glomerular filtration rate, as endogenous creatinine 
clearance, was measured on 103 days in 34 male infants 
during the first week of life. The mean gestational age of 
the babies was 28.5 weeks (median 28; range 25 - 34); the 
mean birth weight was 1.18 kg (median 1.12; range 0.680 - 
1.832) . The mean urine flow rate was 2.57 ml kg -1 h -1 (median 
2.58; range 0.64 - 4.44). 
The mean duration of daily urine collection was 1241 
minutes (median 1420; range 105 - 1800). The mean duration 
of total urine collection was 2.45 days (median 2.38; range 
0.2 - 7) . 
The mean GFR for the 34 infants was 0.57 ml min-1 kg-1 
(median 0.51, range 0.09 - 1.11; 95% confidence interval 
0.49 - 0.66). 
GFR was first assessed in relation to postnatal age. 
GFR (ml min -1 kg1), calculated for each of the first seven 
days of life, is presented for visual inspection in boxplot 
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format (Fig 5.1). The corresponding numerical values are 
shown in Table 5.1. Visual inspection suggests that GFR 
increases between the first and the third days of life and 
then remains relatively constant. The Tukey multiple 
comparison procedure showed that no two groups were 
significantly different at the 0.05 level. Analysis using 
the less rigorous least significant difference multiple 
comparison procedure suggested that GFR on day 1 differed 
from GFR on days 3 and 4. However mutivariate analysis of 
variance failed to substantiate this impression, showing no 
effect of postnatal age, having allowed for between 
baby variation and variation due to gestational age 
(F =0.89, p =0.5). 
GFR was then examined in relation to gestational age. 
Absolute GFR (ml min -1) , GFR factored by body weight (ml min 
kg ) and GFR factored by surface area (ml min 1 m2 1 ) are 
presented as regression plots against gestational age (Fig 
5.2 - 5.4). Absolute GFR increased significantly with 
gestational age (r =0.64, p<0.0001) (Fig 5.2) as did GFR 
factored by surface area (r =0.4, p <0.05) (Fig 5.4); when 
factored by body weight a positive correlation was shown 




The measurement of GFR in neonates has been the 
subject of numerous investigators. Published data have 
however, often been conflicting. GFR is believed to alter 
with postconceptional and postnatal age, yet the pattern of 
maturation has been variably described. There is also 
disagreement over the effect of several clinical 
circumstances on GFR. Engle et al [1983] found no change 
in GFR during the course of hyaline membrane disease, 
unlike Guignard et al [1976] and Costarino et al [1985]. 
Artificial ventilation [Leslie et al 1986] has also been 
held to influence GFR. Couithard and Hey [1985] and 
Stonestreet et al [1983], studying the effect of varying 
fluid intakes, found that this did not change glomerular 
filtration rate. 
Expression of GFR 
Confusion has arisen in the interpretation of 
measurements, in part because of the use of differing 
methods of expression. The conventional "correction" of GFR 
for surface area, used by "adult" nephrologists, would 
appear to have been incorectly applied to the neonate. As 
long ago as 1952, McCance and Widowson questioned the use, 
in paediatric practice, of surface area to standardize GFR. 
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It would be logical to relate GFR to the size of the 
fluid pool affected by the kidney. In the neonate all fluid 
compartments are changing fairly rapidly and correlate 
closely with body weight. Coulthard and Hey [1984] have 
argued elegantly in favour of weight as the best standard 
for glomerular filtration in the newborn. They point out 
that whereas the ratio of surface area to weight changes 
little in adulthood, it falls by one third between 27 weeks 
and term (Fig 5.5). A 70 kg, 1.73 m2 adult, filters 
approximately 140 ml mini; this is equivalent to 80 ml 
mine m2 -1 and 2 ml min-1 kg-1 (Table 5. 2) . To achieve a GFR 
of 80 ml min-1 m2 -1 , an infant weighing 1 kg and with a 
surface area of 0.1 m2,would need to filter 8 ml mini kg1. 
Such an infant actually filters around 0.5 ml min-1 kg1. 
GFR is generally held to be extremely low in the 
preterm infant in comparison to adult values: however when 
GFRs standardized by body weight are compared, the 
magnitude of difference between the 1 kg infant and the 70 
kg adult is closer to fourfold rather than to the 
sixteenfold difference suggested when surface area 
corrected GFRs are compared. 
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Maturation of GFR 
There is general agreement that GFR correlates with 
gestational and postconceptional age [Leake et al 1976 i]. 
The precise pattern of maturation has however been 
described in conflicting ways. Arant [1978], Al- Dahhan et 
al [1983] and Coulthard [1985] describe a shallow gradient 
until 34 weeks becoming abruptly steeper thereafter. These 
authors expressed their results in absolute terms of ml 
min-1. Another group of workers, expressing their 
measurements of GFR corrected for surface area as ml min -1 
m2 -1, describe the converse, that is a rapid increase to 35 
weeks gestation slowing down till term [Guignard 1982; 
Guignard and John 1986; Fawer et al 1979]. They suggest 
that this may be explained by the completion of 
nephrogenesis at 35 weeks. This pattern of maturation has 
not been confirmed by other workers. It has been suggested 
that the apparent slowing of maturation at 35 weeks is an 
analysis related artefact [Coulthard 1985]. When expressed 
per kg body weight, the rate of increase in GFR 
decreases [Coulthard 1985] or disappears. Coulthard has 
analysed data on GFR from 14 previous studies in addition 
to his own. An "overview" of the published data, following 
presentation in similar format, allowed him to draw the 
conclusion that GFR in newborns (measured from the 
third postnatal day), expressed per unit body weight, 
increases linearly in a programmed way which is determined 
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by postconceptional age (Fig 5.6). Data from the present 
study are consistent with these observations (Fig 5.2 - 
5.4) . 
Influence of birth on GFR 
The data presented here suggest that GFR may increase 
over the first two days of life but then remains 
relatively constant between days 3 - 7. It should be 
appreciated however that GFR on the first two days of life 
was found to be significantly lower only when applying the 
less rigorous least significance difference multiple 
comparison procedure. A similar pattern of essentially 
unchanging GFR during the first week of life in preterm 
infants has been described by others [Stonestreet et al 
1983; Arant 1978]. More mature infants display a clear 
increase in GFR during the first week of life [Guignard et 
al 1975; Aperia et al 1981] . This is likely to be due to 
the decrease in renal vascular resistance and increase in 
renal blood flow that has been demonstrated in animal 
studies of the immediate postnatal period [Gruskin et al 
1970]. 
During the first few weeks of postnatal life GFR has 
been believed to show a more rapid rate of increase [Aperia 
et al 1981 ; Fawer et al 1979]. Coulthard [1985] has 
replotted this data, expressing GFR by projected weight 
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rather than by actual weight and has shown this apparent 
sharp rise after birth is an artefact due to a 
temporary slowing of growth. It is in order to avoid any 
artefactual increase in GFR during the first week of life 
due to postnatal weight loss that GFR has been expressed by 
birth weight rather than actual weight in the study 
described here. 
Comparison with published data derived from "healthy" 
newborns. 
It is widely believed that preterm infants requiring 
ventilatory support are in a state of relative renal 
impairment. It is of interest, therefore, to compare the 
values for GFR obtained in this study, with measurements 
made in healthy infants. Coulthard [1985] measured GFR in 
39 healthy infants using the prolonged inulin infusion 
technique and constructed a formula predicting GFR (ml 
min -1 kg-1) in the first month of life from postnatal age 
(PNA, weeks) and birthweight (BW, kg): 
GFR = 0.24BW + 0.18PNA + 0.45 
The standard error for this prediction was 0.09. The 
mean birthweight and postnatal age for the infants in the 
present study were 1.18 kg and 0.47 weeks respectively. The 
100 
95% confidence interval derived following insertion of 
these values into Coulthard's equation is: 
0.64 - 0.99 (1) 
The 95% confidence interval for GFR (ml min -1 kg -1) 
derived from the present study is: 
0.49 - 0.66 (2) 
Coulthard et al [1985] suggest, however, that 
creatinine clearance measured by reaction rate analysis 
(as in the present study) underestimates inulin clearance 
by approximately 25 %. Correction of interval (2) above 
on the assumption that it represents only 75% of 'true' GFR 
produces the following confidence interval: 
0.65 - 0.88 (3) 
Furthermore Coulthard [1985] compared his measurements 
with data from 14 other published studies of GFR in 
healthy babies and found close agreement. There is 
close agreement between confidence interval 1 
(Coulthard; heathy infants) and confidence interval 3 
(present study; 'sick' infants). Agreement is also found 
in Coulthard's regression equation describing the 
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correlation between GFR (ml min-1 kg-1) and conceptional age 
(CA,weeks), in babies aged 2 -7 days (Fig 5.6), 
GFR = 0.0414CA - 0.4 
and the regression equation derived from the present study 
(Fig 5.3), 
GFR = 0.03GA - 0.23 
where GA = gestational age in weeks. 
It would appear, therefore, from the arguments 
presented above that there is little difference between 
estimates of GFR obtained from healthy preterm infants and 
those representing the typical preterm population of a 
neonatal intensive care unit. 
Changes in GFR in relation to postnatal respiratory 
adaption are discussed in chapter 8. 
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Conclusions 
1. The 95% confidence interval for glomerular 
filtration rate, expressed as endogenous creatinine 
clearance and measured during the first week of life, 
in infants between 25 - 34 weeks gestation, was 
0.49 - 0.66 ml min-1 kg-1. 
2. Infants between 25 -34 weeks gestation may show an 
increase in GFR over the first two days of life but 
show no significant increase from days 3 - 7. 
3. When expressed in absolute terms of ml min -1, GFR, 
measured between 25 - 34 weeks gestation, showed a 
highly significant positive correlation with 
gestational age; when factored by body weight a 
positive correlation was also found, which failed to 
reach significance. 
4. Comparison of published estimates of GFR measured in 
healthy preterm infants and those from the population 
of infants receiving intensive care, studied here, 
show little overall difference. 
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Figure 5.1 
Glomerular filtration rate by postnatal age. 
Box and whisker plot showing medians, interquartile range 





Glomerular filtration rate by postnatal age. 
(medians, interquartile range & extreme values) 
day n minimum Q1 median Q3 maximum 
1 11 0.16 0.24 0.25 0.46 0.62 
2 29 0.03 0.35 0.44 0.59 1.21 
3 24 0.15 0.35 0.53 0.73 1.17 
4 16 0.24 0.35 0.54 0.85 1.17 
5 10 0.16 0.40 0.48 0.67 0.85 
6 8 0.09 0.23 0.50 0.82 1.23 
7 5 0.31 0.34 0.42 0.66 0.90 
(GFR, glomerular filtration rate in ml min-1 kg-1) 
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Figure 5.2 
Regression of glomerular filtration rate (ml mint) on 
gestational age. 
GFR = 0.094GA - 1.99, SE of estimate = 0.27 
r = 0.64, p <0.0001 
Figure 5.3 
Regression of glomerular filtration rate (ml min -1 kg -1) on 
gestational age. 
GFR = 0.03GA - 0.23, SE of estimate = 0.23 
r = 0.28, p = 0.1 
Figure 5.4 
Regression of glomerular filtration rate (ml min -1 m2-) on 
gestational age. 
GFR = 0.46GA - 7.0, SE of estimate = 2.5 























































































































































































































































































































































































































































































































































































































































Surface area to weight ratio by body weight. 
(From Coulthard MG, Hey EN, Arch Dis Child 1984 
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"Corrected" glomerular filtration rate. 
adult preterm neonate 
weight 70 kg weight 1 kg 
SA 1.7 m2 SA 0.1 m2 
ml min-1 140 0.5 
ml min -1 m2 -1 80 5 
ml min-1 kg-1 2 0.5 
(SA, surface area) 
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Figure 5.6 
Glomerular filtration rate by conceptional age. 
(From Coulthard MG, Earl Hum Dey 1985 11:288; 
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URINARY CREATININE EXCRETION AND ESTIMATION OF MUSCLE MASS 
Creatinine is derived from phosphocreatine by a non 
enzymatic process occurring in muscle [Bloch & Schoenheimer 
1939]. In 1947 Borsook and Dubnoff reported that 98% of 
total body phosphocreatine is located in muscle and that 2% 
is converted daily to creatinine and excreted in the urine. 
At steady state therefore, creatinine excretion is an 
indirect measure of muscle mass. The urinary excretion 
rate of creatinine was first used in anthropometric studies 
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as an indirect index of muscle mass in 1938 [Talbot 1938]. 
Creatinine excretion factored by body weight is similarly 
a reflection of the relative amount of muscle in the body 
[Graystone 1968]. 
A knowledge of urinary creatinine excretion has 
several applications; it has been used as an index of 
muscle mass and nutritional status [Heymsfield et al 1983], 
to estimate urine flow rate and to relate the excretion of 
other metabolites [Coulthard et al 1985]. There is limited 
information relating to creatinine excretion in 
extremely immature infants. This chapter presents data 
relating to a typical group of preterm infants. 
Methods 
Continuous urine collections were obtained from the 
study population described in chapter 3 - Methods. 
Mean daily urine flow rate was calculated for each 
infant for each study day using aggregated data from the 4 
hourly time periods of urine collection. In order to 
minimise the risk of inadvertently including infants with 
unrecognised impairment in renal function, data was only 
analysed in infants in whom mean daily urine flow rate 
equalled or exceeded 0.5 ml kg -1 h -1. 
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Urinary creatinine excretion was calculated as the 
product of urine volume and urinary creatinine 
concentration. Creatinine excretion in daily time periods 
was aggregated and standardised to excretion per 1440 
minutes to produce a daily excretion rate. Creatinine 
excretion was factored by body weight on the day of study. 
The relationships between daily creatinine excretion 
and postconceptional age, daily creatinine excretion and 
weight, daily creatinine excretion factored by body weight 
and postconceptional age and daily creatinine excretion 
factored by body weight and weight were studied. As 
repeated measurements were made [O'Brien Smith 1987], 
multivariate analysis of variance was used, allowing for 
between baby differences. Values for daily creatinine 
excretion and daily creatinine excretion factored by body 
weight are analysed following logarithmic transformation 
to stabilise the variances. To assist conceptualisation, 
these data are presented for visual inspection as 
scatterplots. The influence of postnatal age on daily 
creatinine excretion was assessed and found not to vary 
within the study period of seven days having allowed for 
between baby differences and actual weight; data from each 
infant was therefore aggregated to provide a single mean 
daily creatinine excretion rate for each infant in order to 
estimate muscle mass as described below. These results are 
analysed using simple linear regression. 
115 
Muscle mass was estimated using the factor of 20 
suggested by Graystone [1968]; i.e. the excretion of 1 g of 
creatinine per 24 hours derives from 20 kg muscle. (1 mg 
= 8.8 umol creatinine). 
Results 
Continuous urine collections were obtained over 89 
days in 31 babies during the first week of life. The mean 
duration of each daily urine collection was 1276 minutes 
(median 1425; range 105 - 1800). The mean duration of each 
total urine collection was 3744 minutes (median 3465; range 
630 - 9930). Mean daily urine flow rates of less than 0.5 
ml kg-1 h -1 occurred on a total of 13 days in 13 babies. 
The median daily creatinine excretion was 71.4 umol 
kg-1 day-1 (mean 71.4; 95% confidence interval 65.16 
77.64) . 
The median muscle mass as a percentage of birth weight 
was 14.3% (mean 15; 95% confidence interval 13.4 - 16). 
Log creatinine excretion (umol day-1) was found to have 
a significant positive association with actual weight 
(F =5.80, p<0.05) and postconceptional age (F =8.08, p <0.01) 
allowing for between baby differences. There was no 
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significant change with postnatal age (F =2.54, p =0.12) 
having allowed, in addition, for actual weight. 
Log of the ratio of creatinine excretion to body 
weight also showed a significant correlation with both 
weight (F= 11.96,p= 0.001) and postconceptional age 
(F= 12.35,p= 0.001). There was no correlation with postnatal 
age (F =2.55, p= 0.12). 
These data are presented for visual inspection, 
without logarithmic transformation, as scatterplots (Figs 
6.1- 6.6). 
Muscle mass showed a highly significant positive 
correlation with birthweight (r =0.8, p<0.0001) (Fig 6.7) 
and gestational age (r =0.8, p <0.0001) (Fig 6.8). 
Percentage muscle mass showed a positive correlation with 
birthweight (r =0.35, p =0.05) (Fig 6.9) and gestational age 
(r =0.43, p =0.01) (Fig 6.10). The regression equations 
summarizing the relationships between creatinine excretion, 
muscle mass, percentage muscle mass, birthweight and age 
are presented in Table 6.1. 
Birth weight (BW) and gestational age (GA) together 
accounted for 64% of the variance for muscle mass. The 
following regression equation was constructed: 
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muscle mass (g) = 0.145 BW (g) + 10 GA (weeks) - 275 
Analysis of the published summary statistics (Table 
6.2) reveals that creatinine excretion factored by body 
weight does increase with postconceptional age (r =0.8, 
p= 0.01)(Fig 6.11). The relationship is described by the 
following equation, which was derived using weighted least 
squares, with the sample sizes used as weights: 
creatinine excretion = 55.2 + 0.13 post conceptional age 
(umol kg -1 day 1) (days) 
The coefficient of postconceptional age is significant 
at less than 2%. This is consistent with the results of 
the more detailed analysis presented above. 
Discussion 
The benefits accruing from a knowledge of urinary 
creatinine excretion rate have been mentioned above. 
However there is limited data relating to creatinine 
excretion in immature neonates given the problems of 
accurate urine collection; neonates empty their bladders 
incompletely necessitating prolonged collection periods; 
further difficulties are posed by skin breakdown, secure 
perineal adhesion and leakage. There would appear to be 
only three reported studies [Sutphen 1982, Brion et al 
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1986, Al- Dahhan et al 1988] relating to the direct 
measurement of urinary creatinine excretion rate in 
immature infants. 
Coulthard et al [1985] estimated creatinine excretion 
rate from a knowledge of "spot" urinary creatinine 
concentration and urine flow rate in babies of 26 - 40 
weeks gestation during the first week of life. Each of 
these studies, including that reported here, relates to a 
relatively small sample size. An important criticism that 
may be levelled at the studies of Coulthard et al [1985] 
and Al- Dahhan et al [1988] is the use of simple linear 
regression when repeated measurements made on the same 
individual are combined with those from different 
individuals [O'Brian Smith 1987]. Measurements made on the 
same individual on separate occasions are correlated with 
one another and the inclusion of such measures in a simple 
linear regression violates the assumption on which the 
analysis is based. P values thus derived are meaningless. 
The published summary statistics have been analysed 
together with data from this study. Coulthard et al [1985], 
state that the per kg creatinine excretion rate showed no 
relation to gestation and describe a mean excretion rate of 
104 umol kg1 day-1 in the first week of life. Unfortunately 
these authors have not included the statistical data, the 
raw data nor details of the babies postconceptional age and 
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it has therefore not been possible to include their 
observations in the pooled analysis. 
In analysing pooled published data the relationship of 
creatinine excretion factored by body weight with 
postconceptional age, i.e. a significant positive 
correlation, has emerged; this is in keeping with the 
conclusions of this study. Issue must therefore be taken 
with the conclusion of Al- Dahhan et al that "infants of 
postconceptional age 198 - 290 days may be regarded as a 
single population with respect to the excretion of 
creatinine factored by weight" and that of Coulthard et al 
that the per kg creatinine excretion rate is not influenced 
by gestation [Modi & Hutton, In press, 1990]. 
In the examples discussed above, inappropriate 
analysis has led to erroneous conclusions. It is also a 
fundamental statistical precept that an acceptable 
estimation of a "normal" range demands, in the first 
instance, a large sample size; further, given the wide 
dispersion of values about the mean seen with most 
biological data, the validity of attempts to define 
"normal" ranges from samples of small size is questionable 
[Al- Dahhan et al 1988]. Collaboration between workers in 
this field would seem a better approach to estimate 
population characteristics with reasonable accuracy. 
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If creatinine excretion factored by body weight 
increases with postconceptional age it may be inferred 
that the relative amount of muscle in the body increases 
over the age range studied in keeping with changes known to 
occur in older age groups. The classic dissection 
studies of the early German anatomists showed muscle mass 
to be 25% of body weight in full term newborns which 
increases to the adult level of 45% at puberty [Graystone 
1968]. The regression equation deriving percentage 
muscle mass from gestational age (GA) (Table 6.1) is in 
striking agreement, predicting an infant of 40 weeks 
gestation to have a muscle mass of 24% body weight. 
% muscle mass = 0.8GA - 7.93 
The regression equation also predicts a 12% muscle mass in 
the 25 week infant and 19% at 34 weeks. However these 
figures may be underestimates as there is a greater 
proportion of connective tissue in preterm muscle; in 
addition the coefficient of 20 suggested by Graystone 
[1968] has not been validated for application in the 
extremely immature infant. 
Percentage muscle mass was shown to have a better 
correlation with gestational age than with birth weight. 
This suggests that birth weight is a poor reflection of 
relative muscle mass and is in keeping with the parallel 
121 
observation that body water content is both variable 




1. The median daily creatinine excretion in the first 
week of life in babies of gestational ages 25 - 34 
weeks was 71.4 umol kg -1 day-1 (mean 71.4, 95% 
confidence interval 65.16 - 77.64). 
2. Creatinine excretion and creatinine excretion factored 
by body weight showed a significant positive 
correlation with weight and postconceptional age. 
Pooled analysis of published data together with that 
from this study, also revealed that this correlation 
is significant. This correlation is not evident when 
inappropriate methods of analysis are used. 
Muscle mass is estimated from creatinine excretion 
rate. A regression equation is derived predicting 
muscle mass from birth weight and gestational age. 
Muscle mass increases from 12% of birth weight at 25 
weeks gestation to 19% at 34 weeks and 24% at 40 
weeks. This is in agreement with classic dissection 
studies which showed muscle mass to be 25% of body 
weight at term. 
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Figures 6.1 - 6.6 
Scatterplots of creatinine 
kg -1 day-1) by weight (kg) , 
postnatal age (days). 
excretion (umol day 1 and umol 
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Figures 6.7 - 6.8 
Regression plots , with 95% confidence interval for the 
points, of muscle mass (g) on birthweight (kg) and 
gestational age (weeks). The regression statistics are 



































































Figures 6.9 - 6.10 
Regression plots of muscle mass as a percentage of birth 
weight on birth weight (kg) and gestational age (weeks). 
The regression statistics are listed in Table 6.1. 
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Regression plot of pooled published data; daily creatinine 
excretion (umol kg1 day -1) on postconceptional age (days). 







































































































































































































































































































































































































































































































































































Published summary statistics of mean creatinine excretion 
rate at varying postconceptional ages. 
n mean creatinine PCA 
excretion 
Modi & Hutton [In press] 89 71 204 
Sutphen [1982] 15 71 211 
Brion et al [1986] 42 85 216 
Brion et al [1986] 63 97 228 
Al- Dahhan et al [1988] 84 90 238 
Brion et al [1986] 27 106 282 
Brion et al [1986] 22 110 330 
Brion et al [1986] 13 89 367 
Brion et al [1986] 35 120 519 
(creatinine excretion, umol kg-1 day 1 ; PCA, postconceptional 
age in days) 
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7 
URINE FLOW RATE AND OSMOLALITY 
Urine flow rate 
The measurement of urine flow rate is an important part 
of the assessment of renal function in the neonate. 
Unfortunately, as discussed elsewhere in this thesis, it is 
difficult to carry out accurately because of the problems of 
urine collection and because neonates frequently do not void 
completely. Urine osmolality is a frequently measured 
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parameter on 'spot' urine specimens; it has been suggested 
that optimal hydration is assured if urine osmolality is 
maintained within predefined limits [Coulthard & Hey 1985]. 
Immature neonates are regarded as having a limited 
concentrating and diluting capacity. In view of the risks in 
this group of vulnerable infants, of acute volume overload if 
subjected to a high infusion rate and conversely prerenal, 
potentially leading to intrinsic renal failure if dehydrated, 
it cannot be ethical to observe maximum and minimum urinary 
concentrations under such controlled conditions. The aim of 
this part of the study was therefore to observe maximum and 
minimum urine osmolalities achieved in the course of routine 
clinical management and to examine postnatal changes in urine 
flow rate and osmolality. The effects of respiratory function 
on these parameters are described in chapter 8. 
Methods 
Urine osmolality was measured in each of the individual 
sequential time periods throughout the entire study duration 
in the manner described in chapter 3 - Methods. 
Mean daily urine osmolality and mean daily urine flow 




Five hundred and twenty one measurements of urine 
osmolality were made in 34 infants in the first 7 days of 
life. The minimum urine osmolality recorded was 90 mosm 1 -1 on 
the fifth day of life in an infant of 32 weeks gestation. The 
maximum recorded osmolality was 1225 mosm on the second day 
of life in an infant of 29 weeks gestation; this infant had 
a urine flow rate at the time of less than 0.5 ml kg-1 h-1. 
Mean daily urine osmolality for each infant is expressed 
in boxplot format by postnatal age in figure 7.1; the 
numerical values are shown in table 7.1. There appears to be 
little fluctuation with postnatal age, with the median 
osmolality remaining between 345 - 401 mosm 1 -1. Overall, the 
mean daily urine osmolality was 370 mosm 1 -1 (median 366, range 
104 - 739) . 
Mean daily urine flow rate is shown in boxplot format in 
figure 7.2 (numerical values, table 7.2). There appears to be 
an increase between the first and second postnatal days. This 
has been further evaluated using multivariate analysis of 
variance allowing for between baby differences which confirms 
that there is a significant change in urine flow rate with 
postnatal age (F6016 = 8.04, p<0.001) . 
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Discussion 
The observations here confirm that urine flow rate is low 
on the first day of life and rises subsequently. This is 
believed to be secondary to the increase in GFR that occurs 
at this time (chapter 5) and may also in part be due to the 
high circulating levels of arginine vasopressin (AVP) present 
in the infant in the perinatal period (chapter 2). 
It is generally held that a urine output less than 1 ml 
f 1 i kg h s suggestive of impaired renal function. This is 
because in the presence of a renal solute load of 15 mosm 
kg-1 day -1 and an approximate maximum urinary concentration of 
500 - 700 mosm kg water-, solute retention might be expected 
to occur if urine flow rate is less than 1 ml kg-1 day -1 
& infants have 
considerably smaller solute loads on the first day of life, 
and in these infants it may be more appropriate to regard a 
urine flow rate of less than 0.5 ml kg -1 h -1 on day one of life 
and 1 ml kg-1 h-1 thereafter as abnormal. 
High urine flow rates in the immediate newborn period are 
seen in infants with tubular damage, as a physiological 
response to fetal overhydration such as in maternal fluid 
overload and in the presence of polyhydramnios. The author 
[Modi 1988] has observed an infant who was noted to have a 
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high intrauterine urinary flow rate and in whom 
polyhydramnios was present. This infant was born at 28 
weeks gestation and developed moderately severe hyaline 
membrane disease; despite this she had a high urinary flow 
rate of approximately 7 ml kg-1 hr-1 on the first day of life 
which persisted to five days. 
It has been estimated that the most immature preterm 
infants might achieve a maximum urine flow rate of around 7 
ml kg-1 h-1 [Coulthard & Hey 1985] . 
Water balance is maintained by altering urine 
volume and concentration. The ascending limb of the loop of 
Henle and the distal tubule function as the 'diluting' 
segments where reabsorption of solute takes place without 
water. The ability to form urine is dependent 
on the hypertonic medullary interstitium established by the 
loop of Henle countercurrent system. The permeability to water 
of the distal tubule and collecting duct is controlled by 
the action of antidiuretic hormone. It has been shown that 
the peak urine flow of mature infants given a water load is 
the same as that of adults when expressed per unit body water 
[McCance et al 1954]. Coulthard and Hey [1985] have also 
recently challenged the widely held view that newborns have 
a reduced capacity for water excretion. They demonstrated that 
healthy preterm (29 to 34 weeks) babies were able to cope with 
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water intakes ranging from 96 -200 ml kg -1 day -1 from the third 
day of life, sodium intake remaining constant. Other studies 
of the effect of varying fluid loads in tiny babies have 
failed to maintain a constant sodium intake. It is likely 
that the morbidity associated with increased fluid intakes 
is in fact attributable to the increased sodium load [Bell et 
al 1980], mediated by failure to achieve a contraction in 
extracellular fluid volume [Stonestreet et al 1983]. Water and 
sodium should be prescribed independently and in particular, 
the use of 'fixed formula' parenteral solutions is ill 
advised. 
Coulthard and Hey [1985] describe a minimum osmolality 
of 45 mosm kg -1 in a group of healthy infants, of less than 34 
weeks gestation, receiving a liberal fluid intake. They 
estimate that the smallest babies are likely to have an upper 
limit of urine flow of around 7 ml kg-1 h-1, with larger babies 
achieving double this rate. In contrast, in the study here 
involving a group of babies of similar gestational and 
postnatal age but who required ventilatory support, a minimum 
urine osmolality of 90 mosm kg -1 is noted. It may, of course, 
be that maximal diuresis was never achieved in this group of 
babies but in view of the risks of acute volume overload in 
such a clinically compromised group, it would be ethically 
unacceptable to subject these infants to such a procedure. 
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Urine osmolality is known to increase and free water 
clearance to decrease in hypoxic fetal lambs [Robillard et al 
1981]. However the renal response to hypoxia appears to be 
gestation dependent. In lamb fetuses near term, hypoxia has 
been shown to result in a decreased renal blood flow, 
concomitant rise in plasma renin activity, increased AVP 
secretion, decreased heart rate and rise in mean arterial 
pressure. During the reactive hyperaemia seen following 
hypoxia urinary prostaglandin E and F2a rose. In contrast, 
lamb fetuses of greater immaturity showed none of these 
responses other than a rise in AVP in only half the animals 
studied [Robillard et al 1981]. AVP is present in the 
posterior pituitary of the eleven week old human fetus [Levina 
1968]; concentrations increase up to 28 weeks gestation with 
relatively little increase thereafter [Schubert et al 1981]. 
Nephron sensitivity to vasopressin increases with maturity 
[Svenningsen & Aronsen 1974]. High renal prostaglandin E 
production in the newborn may interfere with cyclic AMP 
production and so diminish the cellular action of vasopressin 
[Joppich et al 1979]. 
The immature medulla is characterised by a limited 
osmotic gradient, a consequence of short loops of Henle , low 
urea production and high blood flow through the vasa recta. 
There is evidence to suggest that the renal solute gradient 
is the most important factor limiting the renal response to 
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vasopressin in that maximum urine osmolality achieved is 
higher during hypernatraemic dehydration [Svenningsen & 
Aronsen 1974]. Rees et al [1984] have shown that osmotic and 
volume stimuli are able to stimulate the secretion of 
vasopressin in preterm infants from 26 to 35 weeks 
gestation. In addition peaks of vasopressin secretion occurred 
in response to non osmotic stimuli, resulting in 
inappropriately concentrated urine. They show that despite the 
immature response to AVP the preterm neonate is at frequent 
risk of developing the syndrome of inappropriate AVP 
secretion during, for example, the development of 
pneumothoraces and large periventicular haemorrhage. The 
maximum urine osmolality achieved during their observations 
was 550 mosm kg-1. The data presented here suggest that, given 
an appropriate stimulus, even extremely immature infants are 
produce urine of much higher osmolality. 
Changes in urine flow rate and osmolar clearance are 
further discussed in chapter 13 and in relation to changing 
respiratory function in chapter 8. 
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Conclusions 
1. Urine flow rate was seen to increase between the first 
and second day of life in a group of infants between 25 - 
34 weeks gestation, whereas urine osmolality remained 
relatively constant. 
2. The range of urine osmolality observed in this group of 




Daily urine osmolality (mosm 1 -1) for each infant by postnatal 
age. 
Box and whisker plot showing medians, interquartile range and 















Daily urine osmolality (mosm 1 -1) for each infant by postnatal 
age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 209 259 345 506 739 
2 177 239 353 419 715 
3 216 318 386 443 562 
4 218 313 401 439 544 
5 104 264 356 408 434 
6 174 314 370 416 438 
7 313 345 393 477 641 
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Figure 7.2 
Daily urine flow rate (ml kg-1 h -1) for each infant by 
postnatal age. 
Box and whisker plot showing medians, interquartile range and 




























Daily urine flow rate (ml kg -1 h -1) for each infant by 
postnatal age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 0.05 0.24 0.56 1.17 1.9 
2 0.02 0.68 1.79 2.71 4.52 
3 0.55 1.62 2.52 3.08 5.83 
4 0.81 1.79 2.39 3.44 6.31 
5 1.33 1.71 2.87 3.71 4.55 
6 0.60 1.39 4.74 5.30 




Sodium homeostasis is dependent on the interplay 
between sodium and water balance. Derangements of water and 
sodium balance are commonplace in the preterm infant. There 
continues to be much discussion as to optimal fluid and 
sodium administration in very low birth weight infants 
[Costarino & Baumgart 1986, Lorenz et al 1982]. 
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Sodium retention is a prerequisite of growth and 
characterises the developing fetus and infant. Yet urinary 
sodium losses are high in the preterm infant and in 
immature infants with respiratory disease, are widely held 
to be even higher [Hirsch et al 1980]. 
The early newborn period is characterised, in infants 
of all gestational ages, by a contraction of extracellular 
fluid volume. In preterm infants with respiratory disease 
this contraction is delayed and is marked by the diuresis 
that accompanies improving respiratory function. The loss 
of extracellular fluid entails the loss of sodium, the 
principal extracellular electrolyte. The trigger that 
initiates these postnatal adaptations is not known. The 
purpose of this part of the study was to investigate 
sodium handling during the first week of life 
to examine the influence of respiratory disease. 
Methods 
Thirty four male neonates, of less than 34 weeks 
gestation and requiring ventilatory support from birth, 
formed the initial study group. This initial group is fully 
described in chapter 3 - Methods. 
The volume and sodium content of all intravenous and 
intraarterial fluids, including blood products and flush 
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fluids, was recorded. Blood samples were collected at times 
of clinical sampling upto a maximum of one sample in each 
4 hour period. Urine was continuously collected; infants 
were weighed at birth and at intervals thereafter; these 
techniques and those of sodium, potassium, osmolality and 
creatinine assay and four hourly arterial blood gas 
measurements are described in chapter 3 - Methods. 
Meconium /stool loses were not measured. Frusemide is 
not administered routinely in this neonatal unit and only 
three doses were given during the entire period of study 
observations. Each individual study was terminated when 
leakage of urine from the collection system occurred. 
Sodium intake, sodium output, sodium balance, 
fractional sodium excretion, urinary sodium concentration, 
urinary potassium concentration, the ratio of urinary 
sodium to potassium and the percentage of sodium exchanged 
for potassium in the distal tubule were calculated for each 
baby for each of the first seven days of life. The 
calculation of alveolar -arterial oxygen gradient (AaDO2) and 
fractional sodium excretion (FeNa) are as described in 
chapter 3 - Methods. 
The percentage of sodium exchanged for potassium in 
the distal tubule, which may be considered to reflect the 
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action of aldosterone, was estimated from the following 
formula [Kaloyanides et al 1969]: 
(UK.100)/(UK + UNa) 
Weight loss as a percentage of birth weight was 
calculated daily for each baby and expressed in relation to 
postnatal age. 
(birth weight - actual weight).100 /birth weight 
Analysis in relation to respiratory disease 
Infants who develop respiratory problems secondary to 
immaturity frequently do not display a clear improvement in 
respiratory function in the days following birth. Instead 
hyaline membrane disease may merge into chronic lung 
disease, complicated by patent ductus arteriosus, infection 
and cor pulmonale and ultimately lead to death. The second 
part of this study was designed to examine changes in 
sodium handling in preterm infants who demonstrated a clear 
and sustained improvement in respiratory function. From the 
initial group of 34 infants, 26 were suitable for further 
analysis in relation to respiratory disease on the basis of 
a clear and sustained improvement in respiratory function, 
during the study period, as described below. 
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Aggregated mean daily AaD02 was initially plotted 
against day for each of the 34 babies individually. Babies 
in whom there was a clear and sustained improvement in 
respiratory function were subjected to further analysis 
(n =26). This point of improvement was defined as the first 
day on which the mean daily AaD02 was less than that of the 
preceding day but greater than that of the subsequent day. 
The use of mean daily AaD02 was used to smooth the within 
day variation to allow this precise definition; subsequent 
analysis was based on 4 hourly time periods. 
Initial data exploration involved the use of linear 
regression and two sample T testing. Final analysis 
utilised multivariate analysis of variance, allowing for 
differences between babies, respiratory phases and actual 
AaD02. The simplest adequate model was chosen. 
Multivariate analysis of variance, having allowed for 
between baby differences, was also used to compare the 
following variables during the periods of deteriorating and 
improving respiratory function: AaD02, urine flow rate, 
creatinine clearance, osmolar clearance, free water 
clearance, fractional sodium excretion, urinary sodium to 
potassium ratio, percentage distal sodium exchange, plasma 
sodium, creatinine and osmolality, urinary osmolality. 
158 
Sodium retention and AaDO2 were then plotted against 
time period for each baby individually. Smooth curves were 
fitted through the points using the spline fitting routine 
of SAS (Statistical Analysis System) with a parameter value 
of 50. 
The possibility that any change in sodium "retention" 
was due to the effect of postnatal maturation was explored 
in two ways. Age (as 4 hourly period) was examined in an 
analysis of variance together with respiratory phase and an 
analysis of covariance was performed for the eight babies 
who did not show an improvement in respiratory function 
during the study period. 
Results 
The mean birthweight of the 34 babies comprising the 
initial study group was 1.18 kg (median 1.12, range 0.680 
- 1.832) and mean gestational age 28.5 weeks (median 28, 
range 25 - 34). 
Sodium intake and output, urinary sodium 
concentration, sodium balance, fractional sodium excretion, 
urinary sodium to potassium ratio, percentage distal sodium 
exchange, urinary potassium concentration and weight loss 
as a percentage of birth weight, for the first seven days 
of life, are depicted as box plots showing median, 
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interquartile and extreme values and in tabular form (Figs 
8.1 - 8.9) (Tables 8.1 - 8.9). 
Sodium intake increased over the first five days of 
life (Fig 8.1); sodium output increased over days 1 through 
3 but then appeared to stabilise (Fig 8.2). Though the 
median sodium intake was 3.61 mmol kg-1 day-1 (mean 4.04) 
and median urinary loss 3.96 mmol kg -1 day -1 (mean 4.95) over 
this period, the range of values was wide, intake ranging 
from 0.20 mmol kg -1 day-1 to 24.45 mmol kg-1 day -1 and output 
from 0.25 mmol kg 1 day-1 to 17.42 mmol kg 1 day 1 . 
The median urinary sodium concentration was 88 mmol 
1-1 (mean 87) with a range of values from 9 mmol 1 -1 to 187 
mmol 1 -1 (Table 8.3). Multivariate analysis of variance, 
allowing for between baby variation and gestational age 
influences, demonstrated a significant difference between 
mean urinary sodium concentration on days 1 - 2 (71.3 mmol 
1-1, 95% confidence interval 58.8 - 83.8) and days 3 -7 
(97.7, 95% confidence interval 88.9 - 106.4) (F = 16.74, 
p<0.0001). Although analysis of grouped data showed higher 
urinary sodium concentrations to be associated with higher 
total daily sodium loss, the estimation of daily sodium 
loss from spot urinary sodium concentration, a common 
clinical practice, is likely to be extremely inaccurate. 
The range of measured total daily sodium loss is presented 
for four ranges of urinary sodium in Table 8.10. 
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Median sodium balance was positive for the first two 
days of life but negative on days 3 through 7. A plot of 
cumulative sodium balance for the first week of life shows 
positive balance for the first three days of life, negative 
for the next three and with decreasing negative balance 
attained by day 7 (Fig 8.10). 
Median fractional sodium excretion (Fig 8.5) was 4.6% 
(mean 5.2 %, 95% confidence interval 4.5 -6.3). Linear 
regression showed FeNa to fall with increasing gestational 
age; this effect was confirmed on multivariate analysis of 
variance allowing for postnatal age and between baby 
differences (F = 12.44, p<0.0001). 
Multivariate analysis of variance, allowing for 
gestational age and between baby differences, also showed 
mean FeNa on days 1 -2 (4.44, 95% confidence interval 2.56 
- 6.32) to differ from that on days 3 -7 (6.06, 95% 
confidence interval 5.2 - 6.92) (F = 15.3, p <0.0001). 
The influence of gestational age and postnatal age was 
also examined in relation to the ratio of urinary sodium to 
potassium and percentage distal sodium exchange using 
multivariate analysis of variance. Urinary sodium to 
potassium ratio increased significantly with postnatal age 
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(F =4.14, p= 0.001) (Fig 8.6) but was not influenced by 
gestational age F = 0.48, p = 0.87) having allowed for 
between baby differences. The median ratio over the first 
week was 2.72 (mean 3.69, 95% confidence interval 1.83 - 
5.55); the median ratio on day 1 was 2.08 (mean 2.52, 95% 
confidence interval 1.02 -4.02) increasing to 6.00 (mean 
6.89, 95% confidence interval 0.71 - 13.07) on day 7. 
Percentage distal sodium exchange decreased 
significantly with postnatal age (F =3.18, p<0.01) (Fig 8.7) 
and was not influenced by gestational age (F =1.82, p= 0.09); 
the median value during the first week was 26.89 (mean 
30.24, 95% confidence interval 27.02 - 33.46); the median 
value on day i was 32.84 (mean 39.27, 95% confidence 
interval 27.15 - 51.39): the median value on day 7 was 15.9 
(mean 24.87, 95% confidence interval -0.5 - 49.99). 
Urinary potassium concentration showed no significant 
change with postnatal age (F =1.98, p =0.08) (Fig 8.8). 
Median urinary potassium concentration was 30.03 mmol -1 
(mean 35.87, 95% confidence interval 31.57 - 40.17). 
Weight loss as a percentage of birth weight was 
extremely variable, with many infants showing a failure to 
achieve any postnatal weight loss (Fig 8.9). The median 
weight loss by day 7 was 14.6% (mean 9.24 %). 
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Influence of respiratory function on sodium handling. 
The median birthweight of the 26 babies suitable for 
analysis of sodium handling in relation to respiratory 
function was 1.170 kg (range 0.780 - 1.830) and median 
duration of total study time 3.18 days (range 1.04 - 
11.00). The median birthweight and duration of study for 
the eight babies unsuitable for analysis in relation to 
respiratory function was 1.070 kg (range 0.680 - 1.632) and 
1.56 days (range 0.5 - 3.02). 
Initially a linear regression analysis of pooled data 
for all infants was performed (Fig 8.11). This showed 
sodium balance to increase with AaDO2; i.e. suggested that 
the poorer the respiratory function and greater the AaDO2, 
the greater the sodium retention. The relationship is 
summarised by the regression equation 
sodium balance = - 3.69 + 0.00923 AaDO2 
sodium balance, mmol kg -1 day 1; AaDO2, torr 
The coefficient of AaDO2 is positive, p<0.0001; i.e. 
the correlation of 0.4 is highly significant. 
In the second stage of the analysis, sodium balance 
before the point of improvement in respiratory function was 
compared with sodium balance after the point of improvement 
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using a two sample T test. Sodium balance changed from 
positive (mean 1.42 mmol kg-1 day-1; SD 3.97) during the 
phase of worsening respiratory function to negative (mean 
- (minus) 1.99 mmol kg-1 day1; SD 3.92) during improving 
respiratory function. The T statistic of 3.98 is highly 
significant when compared with a T distribution with 99 
degrees of freedom, p<0.0001. This suggests that the 
decrease in sodium balance is real despite the non 
independence of the daily values. 
Sodium handling during the periods of deteriorating 
and improving respiratory function was then analysed using 
analyses of variance of sodium balance in 4 hourly 
periods. This confirms that the difference before and 
after the improvement in respiratory function is 
allowed for 
between baby differences (3.65 cf. F25,390, p <0.0001) . 
The correlation of sodium balance with AaD02, noted 
initially, is accounted for by the influence of respiratory 
phase, i.e. whether prior to or after the point of 
improvement. Within each respiratory phase there was no 
correlation between sodium balance and AaD02. This 
association is also presented for visual inspection in the 
form of plots of sodium balance and AaDO2 against time 
period for individual infants. These plots reveal, in 18 
of the 26 cases, a temporal relationship between change in 
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sodium balance and change in AaDO2 despite the variation in 
values; changes in sodium handling parallel the changes in 
AaD02 with relative sodium retention occurring during 
deteriorating respiratory function, changing to relative 
sodium loss with the start of improving function. The plots 
are presented in figures 8.12 - 8.18. 
In view of the possibility that any change in sodium 
"retention" might be a consequence of postnatal maturation, 
analysis of variance of sodium "retention" by respiratory 
phase was performed, allowing for postnatal age (as 4 
hourly period). This confirms the highly significant effect 
of respiratory phase (17.65, cf. F1,431, p <0.001) having 
allowed for postnatal age. In addition an analysis of 
covariance for the eight babies who did not show an 
in respiratory function during the study 
period, failed to show any decrease in sodium "retention" 
with postnatal age (1.87, F172, P= 0.176). 
Values for sodium balance, AaD02 and other parameters 
of renal function by respiratory phase are presented in 
Table 8.11. Comparison was made using multivariate analysis 
of variance having allowed for between baby differences. 
The "estimated contrasts" are estimates of the "true" 
difference, having allowed for between baby variation. An 
increase in sodium loss, fractional sodium excretion and 
osmolar clearance is shown during the improving phase of 
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respiratory function with no change in free water 
clearance. 
Discussion 
Sodium handling in the immature infant is 
characterised by three features: urinary sodium losses are 
high, the natriuretic response to a salt load is blunted 
and there is a net stimulus to conserve sodium - a 
prerequisite of growth. 
The first step in the process of sodium reabsorption 
occcurs in the proximal tubule. Here the absorption of 
sodium and water is isotonic and governed by both active 
and passive forces. Physical factors affecting peritubular 
capillary fluid resorption influence sodium transport at 
the proximal tubule [Giebisch 1969]. These factors have not 
been studied in the human preterm neonate. However animal 
studies do not suggest that proximal tubular reabsorption 
is responsible for the sodium retention that characterises 
the infant [Spitzer 1982]. Micropuncture studies of "late 
proximal" tubules at various stages of maturation also 
suggest that the fraction of filtrate reabsorbed is no 
greater than in the adult nephron [Spitzer & Brandis 1974]. 
The sodium retention of infancy must therefore be presumed 
to be due to enhanced reabsorption at the distal tubule. 
Coulthard and Hey [1985] have estimated distal sodium 
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delivery in babies under 34 weeks gestation to be between 
17 and 20% of the glomerular filtrate, a similar value to 
that reported by Rodriguez -Soriano et al [1983]. 
The renin -angiotensin -aldosterone system rather than 
physical forces appear to be significant with regard to 
sodium reabsorption at the distal tubule. Aldosterone 
secretion is relatively elevated in the newborn [Dillon et 
al 1976, Sulyok et al 1979 i]. There is evidence to suggest 
a limited responsiveness of the distal tubule to 
aldosterone in extremely immature infants which increases 
with maturation. The retention of sodium during growth and 
the blunted natriuretic response of the preterm neonate to 
a saline infusion is thus believed to be due to the high 
level of activity of the renin -angiotensin -aldosteone 
system. Conversely the high renal sodium losses of the 
extremely immature infant appear to be due in part to the 
limited responsiveness of the distal tubule to aldosterone 
stimulation [Spitzer 1982]. Sulyok et al [1979 ii], have 
shown that though preterm infants, in response to negative 
sodium balance, are able to augment plasma renin activity 
to values above those found in full term infants, their 
adrenals fail to respond adequately. The high urinary 
sodium losses of the preterm baby [Engelke et al 1978, Ross 
et al 1977, Sulyok et al 1979 ii] have also been attributed 
to poor proximal reabsorption [Sulyok et al 1979 iii]. In 
the newborn rat kidney, both the total reabsorbtive 
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capacity of the proximal tubule and the activity of Na /K 
ATPase, the enzyme determining active sodium transport, 
increase postnatally [Larsson et al 1983]. Fractional 
sodium excretion decreases with increasing gestational age 
to around 0.2% in full term neonates [Siegel & Oh 1976]. 
The wide range of values for fractional sodium excretion 
shown here, with a mean of 5.4 %, accords with the findings 
of other workers [Ross et al 1977, Siegel & Oh 1976]. 
Sodium balance in the first week of life is similarly 
held to be consistently negative [Al- Dahhan et al 1983, 
Butterfield et al 1960, Engelke et al 1978] though a 
criticism that can be levelled at these studies is the 
paucity of data relating to the first two days of life. In 
addition the studies of Al- Dahhan et al and Butterfield et 
al were confined to healthy newborns. Such reports have led 
to the suggestion that infants of less than 35 weeks 
gestation should receive sodium supplements of 4 -5 mmol 
kg-1 day-1 during the first two postnatal weeks [Al- Dahhan et 
al 1983] and recommendations to this effect are now to be 
found in standard textbooks of neonatal care [Roberton 
1986]. In marked contrast, the data presented here show 
cumulative sodium balance to be positive for the first 
three days of life. 
In the fetus in utero a urinary sodium concentration 
in excess of 100 umol 1-1 is predictive of poor renal 
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function [Golbus et al 1985], yet, postnatally, such levels 
are often seen in the presence of ostensibly normal 
function. An increased GFR, such as occurs in the postnatal 
period, without a concomitant increase in tubular 
resorptive capacity would explain this observation and has 
been used as evidence of functional glomerulotubular 
imbalance [Aperia et al 1981, Aperia et al 1983]. A 
morphological imbalance is known to exist in the 
preponderance of glomerular over tubular development 
[Fetterman et al 1965]. The postnatal urine flow rate, 
after the period of initial oliguria, is however similar to 
the intrauterine flow rate despite the increase in GFR. 
Tubular resorptive capacity for water therefore appears to 
have matured pari passu with glomerular filtration, 
suggesting an alternative explanation for the high urinary 
sodium losses in the immediate postnatal period. 
Aldosterone increases sodium absorption and potassium 
excretion at the distal tubule and thus the urinary sodium 
potassium ratio is an index of aldosterone dependent distal 
tubular activity [Ganong & Mulrow 1958]. Similarly the 
percentage of sodium exchanged for potassium in the distal 
tubule may be considered to reflect the action of 
aldosterone. Preterm infants with respiratory disease have 
also been shown to have high aldosterone levels. This study 
has shown a rise in urinary sodium /potassium ratio and fall 
in the percentage of sodium exchanged for potassium in the 
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distal tubule with postnatal age in preterm infants with 
respiratory disease, during the first week of life. This 
might imply a decrease in aldosterone concentration, 
decreasing tubular responsiveness to aldosterone or another 
natriuretic stimulus. Siegel et al [1973] found aldosterone 
levels to be similarly elevated in infants both with and 
without hyaline membrane disease. Tubular responsiveness is 
believed to rise with maturation and to be accelerated 
after birth [Al- Dahhan 1983]. 
It would appear therefore that an alternative 
natriuretic stimulus is responsible for the increased 
urinary sodium losses in this group of infants. This 
conclusion is further strengthened by the finding that 
urinary potassium losses show no change with postnatal age. 
The question of an alternative natriuretic stimulus is 
further discussed in the next section. 
The influence of respiratory function. 
Following birth, the neonate experiences a contraction 
in extracellular fluid volume [Shaffer et al 1986 i] , with 
concomitant net loss of sodium, the principle extracellular 
electrolyte. It thus appears that the stimulus to retain 
sodium that characterises the growing infant is temporarily 
overruled during the period of postnatal adaptation. It is 
not known what triggers the postnatal contraction in 
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extracellular fluid volume. It may be argued however, that 
a negative sodium balance in the first day or days of life 
is an appropriate response to the onset of postnatal 
existence. 
In healthy, mature infants the postnatal contraction 
in extracellular fluid volume occurs rapidly and relatively 
imperceptibly, only marked in some measure by varying 
degrees of weight loss. In the immature infant with 
respiratory disease, the postnatal contraction in 
extracellular fluid volume is delayed and occurs with the 
well recognised diuresis that accompanies improving 
respiratory function. The mechanism of this diuresis has 
been the subject of several studies but has not yet been 
adequately explained [Costarino et al 1985, Engle et al 
1983, Heaf et al 1982]. 
The data presented here suggest that the diuresis that 
accompanies improving respiratory function in preterm 
infants may be consequent on an increase in sodium 
excretion. Earlier suggestions that the diuresis 
represented an improvement in renal function consequent on 
improved oxygenation [Cort 1962, Guignard et al 1976] were 
refuted when it was shown that the diuresis was not 
initiated subsequent to the improvement in respiratory 
function [Engle et al 1983, Heaf et al 1982, Langman et al 
1981]. Certain authors [Costarino et al 1985, Engle et al 
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1983, Heaf et al 1982, Langman et al 1981] have concluded 
from their findings that diuresis precedes the improvement 
in respiratory function. However careful examination shows 
that their data may equally be interpreted as showing that 
the start of diuresis follows the start of improvement in 
respiratory function and that continuing diuresis then 
accompanies continuing respiratory improvement. 
The data presented here characterise the alterations 
with respiratory improvement as that of a natriuresis, with 
increased sodium loss, fractional sodium excretion and 
osmolar clearance but with no increase in free water 
clearance (Table 8.11). Costarino et al [1985] interpret 
their data as characterising a water diuresis and the 
elimination of an endogenous water load. They refute the 
possibility that the increased urine flow follows an 
increase in solute excretion despite data showing an 
increase in sodium excretion during the diuretic phase and 
a change in mean sodium balance from -0.1 mEq kg -1 day-1 in 
the prediuretic phase to -0.9 and -1.1 mEq kg -1 day1 in the 
diuretic and post diuretic phases. Although this difference 
is not significant the sample size of six infants lacks 
power; given a standard deviation of 2.0 and if the 
difference of 0.8 mEq kg -1 day1 were real, at least 30 
babies would be needed to achieve a 50% chance of reaching 
10% significance. Their data may therefore be interpreted 
as lending support to the findings presented here. 
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Changes in sodium excretion cannot be attributed to 
changes in urine flow rate. Coulthard and Hey [1985] have 
shown that preterm babies are able to maintain a stable 
sodium balance despite fluctuations in urine flow rate. 
Engle et al [1983] ruled out a primary effect on water 
handling mediated by arginine vasopressin, showing no 
change in plasma or urinary levels during the diuretic 
phase. It has been argued that the reduction in sodium 
excretion is secondary to a fall in GFR. However a reduced 
capacity for sodium excretion cannot be attributed per se 
to a low GFR [Spitzer 1982]; a GFR of 0.25 ml kg1 min-1 
will, in a 1 kg infant, still result in the hourly 
filtration of approximately 2 mmol of sodium. A hypoxic 
renal insult is, in addition, likely to result in tubular 
loss of sodium. In contrast it has been shown here, that 
during deteriorating renal function there is a net stimulus 
to retain sodium. 
Recently there has been much speculation as to the 
role of human atrial natriuretic peptide (ANP) during 
postnatal adaptation [Shaffer et al 1986 ii, Tulassay et al 
1987, Kojima et al 1987]. ANP is, in the neonate, released 
from the left atrium in response to increases in left 
atrial pressure [Andersson et al 1988]. It may be 
postulated that the postnatal fall in pulmonary vascular 
resistance and increased left atrial return will lead to 
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ANP release. Kojima et al [1987] report a rise in 
concentration of ANP during the diuretic phase of 
respiratory distress syndrome; these workers did not 
however study the relationship between respiratory function 
and level of ANP. They suggest instead that endogenous 
water overload and an expanded extracellular volume may be 
responsible for the release of ANP in the newborn. Tulassay 
et al [1987], though showing that plasma ANP, in full term 
neonates, rises during the period of early postnatal weight 
loss and falls as weight gain commences, failed to examine 
sodium handling during these changes. Shaffer et al [1986 
ii] also describe raised levels of ANP in ventilated, 
preterm infants, but claim no correlation exists between 
ANP concentration and sodium excretion. This interpretation 
is open to criticism given the lack of longitudinal data; 
sequential measurements in individual babies are necesssary 
for, as we have shown, there is considerable between baby 
variation in sodium excretion. 
Negative sodium balance, in infants of less than 34 
weeks gestation, is held to be the norm in the first two 
weeks of life [Judd et al 1987]. This belief is based on 
studies in healthy infants. Equally, infants with 
respiratory distress are held to have a greater degree of 
renal salt loss [Hirsch et al 1980]. This study shows that 
changes in sodium handling closely follow changes in 
respiratory function as measured by AaDO2 [Modi & Hutton 
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1990]. Prior to the improvement in respiratory function, 
these infants continued to exhibit a net stimulus to retain 
sodium, behaving as though still in utero. After the 
improvement in respiratory function sodium retention 
changed to sodium loss. This change in sodium handling is 
highly statistically significant; the temporal relationship 
has also been demonstrated in the form of longitudinal data 
for individual infants presented as small scale time plots. 
During postnatal respiratory adaptation, including 
recovery from hyaline membrane disease, pulmonary vascular 
resistance falls, increasing left atrial return. It may be 
speculated that the association demonstrated here, between 
sodium handling and respiratory function, may be explained 
by the rise in the level of a natriuretic agent triggered 
by an increase in pulmonary venous return; in other words 
that a change in sodium handling, caused by a primary 
natriuretic stimulus, brought about by postnatal 
respiratory adaptation, may be the trigger that initiates 
the contraction in extracellular fluid volume that 
characterises early postnatal existence in all gestational 
age groups; if so, these observations lend support to the 
suggestions that the natriuretic agent, atrial natriuretic 
peptide, is important in postnatal adaptation. Further 
studies are clearly necessary to clarify these 
relationships. 
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Estimated changes in extracellular fluid volume. 
A plot of cumulative sodium balance for the first week 
of life shows positive balance for the first three days of 
life, negative balance for the next three days and then 
decreasing negative balance on day seven (Fig 8.10). By the 
end of the first week of life the infants had lost 
approximately 10% of their birth weight. The cumulative 
sodium balance at this time was - (minus) 4.7 mmol kg -1 (Fig 
8.10). As extracellular fluid is isotonic, such a sodium 
loss corresponds to an extracellular volume loss of 
approximately 30 ml kg-1 or 3 %. The additional 7% weight 
loss must therefore presumably represent catabolic losses. 
Stonestreet et al [1983], studying a comparable group of 
low birth weight infants receiving a 'high' sodium intake 
of 4.5 mmol kg-1 day-1, describe a weight loss of 11.8 %, but 
similarly to the study reported here, only a slight 
decrease in extracellular fluid volume (ECFV) as measured 
by inulin space. It is uncertain what constitutes optimal 
postnatal extracellular space contraction but it is likely 
that it should be in excess of 3 %. Friis- Hansen [1971] 
showed the extracellular fluid compartment in infants of 28 
- 32 weeks gestation to be aproximately 52% of total body 
weight and Kagan et al [1972] describe this space, at 6 
days of age, in a similar group of infants, to be of the 
order of 40 %, suggesting a 12% reduction. In the study by 
Stonestreet et al, the group of infants receiving a 'low' 
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sodium intake of 3.1 mmol kg-1 day -1 achieved an ECFV 
contraction of about 7% 
Inappropriate sodium and water administration will 
eventually lead to volume overload and expansion of the 
extracellular space [Janovsky et al 1967]. Stonestreet et 
al [1983] have shown a high sodium and water intake to 
inhibit the normal postnatal contraction of the 
extracellular fluid compartment. Atrial natriuretic peptide 
is known to be increased in the presence of volume overload 
[Rascher et al 1985; Lang et al 1985]. Iatrogenic expansion 
of the extracellular space stimulating natriuresis may thus 
be responsible for the large sodium losses often seen in 
sick, preterm babies who are also strikingly oedematous. In 
addition, a delay in ECFV contraction may underly the 
increased morbidity in terms of patent ductus arteriosus, 
respiratory disease and necrotising enterocolitis, 
described in infants receiving high rate intravenous 
infusions of sodium and water [Bell et al 1980; Bell & Oh 
1983]. Vanpee et al [1988] have recently presented evidence 
to show that the high sodium losses of immature infants may 
not be due to renal wastage; they suggest that extrarenal 
factors may be responsible. 
The infants in the study reported here received a mean 
daily sodium intake of 4.04 mmol, a figure similar to the 
high intake group of Stonestreet et al. The data presented 
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here suggest that a high catabolic weight loss masks the 
restricted extracellular fluid loss. It would seem that in 
view of the possible consequences of an expanded 
extracellular fluid space discussed above, sodium 
supplementation should be delayed until after the period of 
physiological diuresis and should then be instituted at a 
rate sufficient to allow for the high urinary salt losses. 
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Conclusions 
1. The median urinary sodium concentration in the group 
of infants studied was 88 mmol 1-1 (mean 87); the 
median fractional sodium excretion was 4.6% (mean 
5.4 %); the median urinary sodium to potassium ratio 
was 2.72 (mean 3.69); urinary sodium concentration, 
fractional sodium excretion and urinary sodium to 
potassium ratio showed a significant increase with 
postnatal age during the first week of life. 
2. Fractional sodium excretion fell significantly 
with increasing gestational age; urinary sodium to 
potassium ratio and percentage distal sodium exchange 
were uninfluenced by gestational age. 
3. Positive sodium retention is seen in preterm babies 
with respiratory disease; sodium retention changes to 
sodium loss at a point coinciding with improvement in 
respiratory function. 
4. The diuresis that accompanies the improvement in 
respiratory function in infants with hyaline 
membrane disease, is characterised as a 
natriuresis, with increased creatinine clearance and 
osmolar clearance but unchanged free water clearance. 
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5. Contraction in extracellular fluid volume probably 
accounts for an estimated 3% of weight loss during the 
first week of life in this group of infants - who 
received early sodium supplementation; the remaining 
weight loss may represent excessive catabolism. 
Hypotheses 
1. The diuresis that signals improving respiratory 
function during the course of hyaline membrane disease 
is brought about by a change in sodium handling. 
This may be mediated by the release of atrial 
natriuretic peptide triggered by the fall in pulmonary 
vascular resistance and increased left atrial return, 
that characterises improving hyaline membrane disease. 
This may also be the mechanism triggering the 
extracellular fluid volume contraction that is a 
feature of postnatal adaptation in newborn infants of 
all gestational ages. 
2. The high urinary sodium losses that are a feature of 
early postnatal life, in extremely immature infants, 
may be a consequence of delayed contraction of the 
extracellular space brought about by inappropriate 
early sodium supplementation. 
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Figure 8.1 
Sodium intake (mmol kg -1 day1) by postnatal age. 
Box and whisker plot showing medians, interquartile range 
and extreme values. The numerical values are listed over 
(Table 8.1). 
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Sodium intake (mmol kg -1 
(medians, interquartile 
day -1) by postnatal age. 
range & extreme values) 
day minimum Q1 median Q3 maximum 
1 0.26 0.48 1.11 5.47 24.45 
2 0.35 1.46 3.04 4.92 12.00 
3 0.78 2.42 3.40 4.60 12.30 
4 0.20 2.27 3.50 4.45 6.24 
5 0.34 2.56 5.73 6.46 7.48 
6 2.38 4.00 4.84 6.50 7.48 
7 3.47 3.77 4.63 6.85 7.69 
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Figure 8.2 
Sodium output (mmol kg -1 day1) by postnatal age. 
Box and whisker plot showing medians, interquartile range 
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Sodium output (mmol kg -1 day -1) by postnatal age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 0.25 0.64 1.43 1.78 4.69 
2 0.54 1.20 2.54 4.18 17.34 
3 0.73 3.30 6.16 9.52 14.45 
4 1.24 3.87 5.09 9.08 17.42 
5 1.39 2.47 5.34 8.94 12.85 
6 0.35 2.04 5.35 10.52 12.92 
7 1.38 1.41 4.57 8.00 9.58 
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Figure 8.3 
Urinary sodium concentration (mmol l-1) for each baby 
by postnatal age. 
Box and whisker plot showing medians, interquartile range 
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Table 8.3 
Urinary sodium concentration (mmol 1 -1) for each baby 
by postnatal age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 9 44 59 88 163 
2 13 42 65 99 178 
3 39 69 97 139 187 
4 42 74 108 127 147 
5 28 66 102 127 142 
6 24 41 99 119 127 
7 43 54 91 122 126 
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Figure 8.4 
Daily sodium balance (mmol kg -1 day) by postnatal age. 
Box and whisker plot showing medians, interquartile range 


















Daily sodium balance (mmol kg -' day 1) by postnatal age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 -1.90 -0.14 1.15 4.65 19.76 
2 -14.67 -2.20 0.23 4.30 9.46 
3 -8.98 -6.12 -2.76 0.34 9.25 
4 -13.70 -5.49 -2.08 -0.30 4.16 
5 -6.40 -5.12 -1.96 1.47 4.59 
6 -7.40 -5.74 -0.86 4.34 6.06 
7 -4.29 -4.07 -0.66 5.46 6.28 
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Figure 8.5 
Fractional sodium excretion by postnatal age. 
Box and whisker plot showing medians, interquartile range 







Fractional sodium excretion by 
(medians, interquartile range & 
postnatal age. 
extreme values) 
day minimum Q1 median Q3 maximum 
1 0.93 1.31 2.46 3.40 13.40 
2 0.45 1.66 3.14 5.33 35.21 
3 1.42 2.55 4.86 8.13 32.42 
4 1.13 4.39 6.00 7.51 10.87 
5 2.67 3.17 6.04 9.86 12.57 
6 0.86 2.71 5.58 8.99 13.78 
7 1.81 2.03 6.17 10.28 12.03 
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Figure 8.6 
Urinary sodium to potassium ratio by postnatal age. 
Box and whisker plot showing medians, interquartile range 







Urinary sodium to potassium ratio 
(medians, interquartile range & 
by postnatal age. 
extreme values) 
day minimum Q1 median Q3 maximum 
1 0.22 0.79 2.08 3.19 9.91 
2 0.54 1.14 2.20 2.82 11.14 
3 0.54 1.31 2.31 4.37 10.61 
4 0.90 2.60 3.38 4.87 9.30 
5 1.03 3.21 6.49 7.77 30.40 
6 1.69 2.76 3.80 11.03 11.98 
7 0.63 1.41 6.00 13.24 14.91 
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Figure 8.7 
Percentage distal sodium exchange by postnatal age. 
Box and whisker plot showing medians, interquartile range 
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distal sodium exchange 
interquartile range & 
by postnatal age. 
extreme values) 
day minimum Q1 median Q3 maximum 
1 9.17 23.89 32.84 56.36 82.00 
2 8.24 26.17 31.24 46.68 64.92 
3 8.61 18.60 30.29 43.33 64.88 
4 9.71 17.03 22.87 27.78 52.56 
5 3.19 11.43 13.35 25.68 49.16 
6 7.70 8.31 20.84 26.59 37.21 
7 6.28 7.42 15.90 51.29 61.40 
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Figure 8.8 
Daily urinary potassium concentration (mmol 1-1) for each 
baby by postnatal age. 
Box and whisker plot showing medians, interquartile range 




Daily urinary potassium concentration (mmol 1-1) for each 
baby by postnatal age. 
(medians, interquartile range & extreme values) 
day minimum Q1 median Q3 maximum 
1 16.5 21.5 30.9 41.9 80.4 
2 15.6 22.9 30.2 60.2 109.3 
3 6.9 30.3 40.3 53.9 80.7 
4 12.9 19.2 29.5 43.5 70.2 
5 3.4 10.8 19.9 25.5 63.9 
6 10.6 11.3 16.2 29.4 35.7 
7 5.7 7.2 21.8 75.9 90.7 
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Figure 8.9 
Weight loss (birthweight - actual weight) as a percentage 
of birth weight by postnatal age. 
Box and whisker plot showing medians, interquartile range 





T T T 
2 OMf OW 4 OW a/ ? 
197 
Table 8.9 
Weight loss as a percentage of birth weight by postnatal 
age. 
(medians, interquartile range & extreme values) 
day minimum Q, median Q3 maximum 
1 -1.59 0.00 0.36 2.62 3.60 
2 -18.13 -1.71 1.78 4.47 13.77 
3 -9.60 -0.96 3.23 9.58 24.72 
4 -12.60 -0.22 6.46 14.49 21.47 
5 -7.12 -2.41 5.60 12.88 27.24 
6 -6.01 -0.75 7.31 20.40 26.34 
7 -8.49 -7.97 14.60 23.78 26.39 
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Table 8.10 
Range of measured daily sodium excretion compared with 
urinary sodium concentration noted on ""spot" samples 
obtained on the same days. 
Range of daily sodium urinary sodium concentration 
excretion (mmol kg-1) (mmol 1 -1) 
0.11 - 11.57 <50 
0.09 - 18.72 50 - 100 
0.44 - 18.72 100 - 150 
1.64 - 14.28 >150 
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Figure 8.10 
Cumulative sodium balance (mmol kgf) for the first week 






 l a 
4 




1 u gi% 













































































































































































































Figures 8.12 - 8.18 
Time plots of AaDO2, urine flow rate and sodium retention by 
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Sodium balance, AaD02 and parameters of renal function by 
respiratory phases, presented as mean (SD) with estimated 
contrasts as determined by multivariate analysis of 
variance. 
* p <0.01; comparison was made using multivariate analysis 






348 (189) 56 
sodium intake 0.16 (0.22) 0.17 (0.14) 0.0017 
sodium balance* 1.42 (3.97) - 1.99 (3.92) 1.92 
urine flow rate* 1.2 (1.36) 2.8 (2.15) -0.86 
Ccr* 0.24 (0.25) 0.47 (0.27) -0.09 
Cosm* 0.017 (0.03) 0.048 (0.04) -0.01 
CH2O - 0.001 (0.01) - 0.003 (0.02) 0.00013 
FeNa* 4.32 (5.11) 5.67 (4.13) -0.88 
plasma sodium 139 (6.3) 140 (6.5) -0.59 
plasma creatinine 112 (40) 110 (31) -3.08 
plasma osmolality 291 (21) 294 (20) -3.05 
urine osmolality* 359 (155) 364 (131) 17.93 
fluid intake* 93 (42) 106 (38) -6.11 
(AaDO2, alveolar arterial oxygen gradient in torr; sodium 
intake, mmol kg -1 day-1; sodium balance, mmol kg -1 day-1; urine 
flow rate, ml kg-1 h-1; Ccr, creatinine clearance in ml 
min -1 kg -1 ; Cosm, osmolar clearance in ml min -1 kg-1; CH2O, 
free water clearance in ml min -1 kg -1; plasma sodium, mmol 
1-1; plasma creatinine, umol 1-1; plasma osmolality, mosm 




Hyperglycaemia is a not uncommon occurence among 
preterm infants receiving intravenous glucose infusions 
[Dweck & Cassady 1974]. The hazards of hyperglycaemia 
include hyperosmolality and, it is also generally believed, 
an osmotic diuresis [Miranda & Dweck 1977]. Hyperosmolality 
may lead to the adverse neurological consequences of 
intracellular acidosis, disruption of the blood brain 
barrier, potentiation of bilirubin toxicity and 
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intracranial haemorrhage [Finberg 1967; Luttrell & Finberg 
1959; Rapoport et al 1972]. In view of the possible 
neurological consequences of hyperosmolality it cannot be 
considered ethically acceptable to expose an infant to 
hyperglycaemia deliberately. The only legitimate manner 
in which to study hyperglycaemia in the human neonate is to 
observe prospectively the occurrence of hyperglycaemia 
during the course of routine clinical management. 
Methods 
The renal effects of hyperglycaemia were assessed in 
a group of preterm infants who developed hyperglycaemia 
during the course of routine clinical care. Each baby 
formed part of the larger study of renal function in 
the first week of life in preterm infants. The infants in 
this larger study underwent continuous collection of urine 
in four hourly time blocks and serial sampling of blood for 
biochemical assay including glucose assay, as described in 
chapter 3 - Methods. 
Hyperglycaemia was defined for the purposes of this 
study as a blood glucose of or exceeding 10 mmol 1 -1. 
Elevated blood glucose levels were, in each case, confirmed 
on repeat assay. Those infants who developed hyperglycaemia 
were subjected to further analysis. Parameters of renal 
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function during hyperglycaemia were compared with periods 
of normoglycaemia in the same infants. 
No infant was receiving enteral feeds and intravenous 
infusion volumes were noted as described in chapter 3 - 
Methods. No baby received treatment with insulin and the 
hyperglycaemia was treated by a reduction in glucose 
infusion rate whilst maintaining a constant fluid intake. 
No attempt was made to influence clinical management. 
Glucose infusion rates were calculated from a 
knowledge of dextrose concentration in the fluid 
administered. Excretion rates were calculated as the 
product of urine concentration and urine flow rate; 
filtered loads as the product of plasma concentration and 
creatinine clearance rate and fractional excretion as 
excretion rate divided by filtration rate. 
Glomerular filtration rate was equated with creatinine 
clearance and calculated as creatinine excretion rate 
divided by plasma concentration. Osmolar clearance was 
calculated as osmolar excretion rate divided by plasma 
osmolality; free water clearance as urine flow rate minus 
osmolar clearance; tubular reabsorption of glucose as 
filtered glucose minus excreted glucose. Data are expressed 
per kilogram body weight. 
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Multivariate analysis of variance, allowing for 
between baby differences and gestational age, was used to 
compare parameters of renal function during the periods of 
hyperglycaemia with periods of normoglycaemia. 
Results 
Fourteen of the 34 babies studied developed 
hyperglycaemia (defined as a blood glucose exceeding 10 
mmol 1-1) during 21 four hourly periods over the course of 
this study. In these same infants, normoglycaemia was 
observed during 19 four hour periods, on the same days of 
life. Birth weights, in these 14 infants, ranged from 680 
g to 1618 g (median 1006 g) and gestational ages from 25 to 
32 weeks (median 27). 
The mean blood glucose during the hyperglycaemic 
periods was 15.8 mmol 11 (median 13.7, range 10.3- 26.0); 
mean urinary glucose 16.9 mmol 1-1 (median 14.9, range 
0.2- 52.0); the glucose infusion rate averaged 7.7 mg kg-1 
min-1 (median 7.7, range 1.17 -17.6). 
Tables 9.1 - 9.4 show the clinical data, parameters 
of renal function, sodium excretion and water and solute 
excretion during the periods of normoglycaemia and 
hyperglycaemia. Values are presented as means and standard 
deviations; comparisons were made using multivariate 
216 
analysis of variance allowing for gestational age and 
between baby differences. 
During hyperglycaemia the infants had, as expected, a 
significantly higher filtered glucose load and urinary 
glucose concentration. Plasma sodium concentration and 
filtered sodium load did not differ during hyperglycaemia 
and normoglycaemia, but fractional sodium excretion and 
sodium excretion were significantly lower during 
hyperglycaemia. 
There was no significant increase in urine flow rate, 
ratio of urine output to fluid intake, fractional urine 
flow, osmolar excretion, osmolar clearance and free water 
clearance during periods of hyperglycaemia. Plasma 
osmolality was higher during hyperglycaemia but the 
difference did not reach significance. 
Discussion 
A limitation of this study is the uncertainty of the 
precise duration of hyperglycaemia. Nevertheless the 
approach used here is justified in view of the 
inacceptability of deliberately subjecting an infant to 
hyperglycaemia and the arguments presented above; in 
addition the occurence of hyperglycaemia and glycosuria 
are both clearly demonstrated. 
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The variability of glucose tolerance in such a 
population is exemplified by the similarity of glucose 
infusion rates during normoglycaemia and hyperglycaemia and 
by the wide range of glucose infusion rates over which 
hyperglycaemia occurred (1.17 - 17.6 mg kg -1 mint). 
Immature infants are prone to hyperglycaemia. 
Contributory factors are believed to be a smaller tissue 
pool of fat and skeletal muscle for glucose disposal and 
persistent endogenous glucose production. Newborn lambs 
[Cowett et al 1978] and preterm rhesus primates [Sherwood 
et al 1977] have been shown to maintain endogenous glucose 
production in the presence of hyperglycaemia. Critically 
ill infants are more prone to develop glucose intolerance 
and hyperglycaemia [Lilien et al 1979]. The aetiology of 
hyperglycaemia in immature, stressed infants is not due to 
absolute hypoinsulinaemia [Lilien et al 1979], but high 
circulating levels of insulin suggest it may be the result 
of end organ unresponsiveness. 
Although Bier et al [1977] showed that mean 
endogenous glucose production in a group of preterm infants 
was 5.46 mg kg-1 min-1 this measure has little practical 
application as both glucose needs and glucose tolerance in 
the vulnerable preterm infant are so variable. 
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Creatinine clearance remained unchanged during 
hyperglycaemia. Creatinine clearance has been shown to 
increase during the infusion of hypertonic glucose 
infusions in infants [Brodehl et al 1972]; however 
considerably higher blood glucose levels were attained than 
in the study reported here. Stonestreet et al [1980], 
studying low birth weight infants also reported no 
significant increase in glomerular filtration rate. 
Tubular reabsorption of glucose increased during 
hyperglycaemia but percentage tubular reabsorption remained 
unchanged suggesting that this degree of hyperglycaemia did 
not saturate the proximal tubular glucose reabsorptive 
sites. 
Fractional sodium excretion and urinary sodium 
excretion decreased during hyperglycaemia. This is 
difficult to understand. Baker & Kleinman [1974] showed 
that newborn puppies excreted more sodium during glucose 
loading due to inhibition of proximal tubular sodium 
reabsorption. However they also found a greater sensitivity 
of the neonatal proximal tubule to the osmotic effect of 
glucose - an observation at variance with the results 
presented here. Interestingly these workers showed that 
glomerular blood flow, as measured by radioactive 
microspheres, was redistributed towards inner cortical 
nephrons during glucose loading in puppies but not in adult 
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dogs. The intrarenal circulation of the neonate is labile 
and subject to redistribution secondary to a number of 
stimuli [Aperia et al 1977]. The inner cortical nephrons 
are more mature than the outer nephrons [Potter 1965]; they 
therefore might be expected to have a greater capacity for 
sodium reabsorption and hence provide an explanation for 
the decreased sodium excretion in the study reported here. 
Of particular interest is that no evidence of an 
osmotic diuresis was found. Urine flow rate, fractional 
urine flow and the ratio of fluid intake to urine output 
remained unchanged. Though this has been reported by other 
workers [Stonestreet et al 1980 ; Cowett et al 1979], 
osmotic diuresis is still cited as a common complication of 
hyperglycaemia in preterm neonates receiving standard 
clinical care [Miranda & Dweck 1977]. However it would seem 
that, unlike the situation in older infants, the immature 
kidney appears unable to hyperfiltrate in the presence 
of hyperglycaemia. 
The danger of hyperglycaemia, to the immature infant, 
over the ranges described here, thus lies in the possibilty 
of associated hyperosmolality and not with the development 
of an osmotic diuresis. 
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Conclusions 
1. Hyperglycaemia, with blood glucose concentrations 
between 10 - 26 mmol 1 -1, occurred at glucose infusion 
rates ranging from 1.17 - 17.6 mg kg-1 min-1, in a group 
of neonates between 25 - 32 weeks gestational age. 
2. This degree of hyperglycaemia did not result in an 
osmotic diuresis. 
3. This degree of hyperglycaemia was associated with a 
significant decrease in fractional sodium excretion 
and urinary sodium loss. 
Hypothesis 
In the extremely preterm infant, hyperglycaemia may 
result in a redistribution of intrarenal blood flow to 
the salt retaining inner cortical nephrons. 
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Table 9.1 
Clinical data during periods of normoglycaemia and 
hyperglycaemia. 
blood glucose 
<10 mmol 1 -1 
blood glucose 
>10 mmol 1 -1 
F sig. 
of F 
bgluc 5.6 (2.1) 15.8 (4.7) 56.8 <0.001 
posm 289 (18.3) 299 (13.5) 0.76 NS 
per 101 (34.8) 110 (21.1) 0.08 NS 
pna 142 (6.8) 141 (5.5) 0.90 NS 
ugluc 9.2 (11.8) 16.9 (14.3) 7.22 0.01 
uosm 360 (123) 352 (84) 0.46 NS 
ucr 1497 (1116) 1496 (677) 0.12 NS 
una 97 (40) 84 (37) 6.19 0.02 
[Values are presented as mean (standard deviation); 
bgluc, blood glucose in mmol 1-1; posm, plasma osmolality 
in mosm 1-1; per, plasma creatinine in mmol 1 -1; pna, 
plasma sodium in mmol 1-1; ugluc, urinary glucose in mmol 
1-1; uosm, urinary osmolality in mosm 1-1; ucr, 




Parameters of renal function during periods of 
normoglycaemia and hyperglycaemia. 
blood glucose blood glucose F sig. 
<10 mmol l -1 >10 mmol 1-1 of F 
ccr 0.599 (0.29) 0.446 (0.31) 1.22 NS 
fg 0.0035 (0.002) 0.007 (0.006) 10.07 <0.01 
trg 0.003 (0.002) 0.007 (0.006) 9.08 <0.01 
ptrg 88 (13.2) 92 (7.7) 0.8 NS 
glucin 7.9 (2.8) 7.7 (3.4) 0.09 NS 
glucexc 0.027 (0.035) 0.033 (0.037) 0.87 NS 
[Values are presented as mean (standard deviation); ccr, 
creatinine clearance in ml min -1 kg-1; fg, filtered glucose 
in mmol kg-1 min -l; trg, tubular reabsorption of glucose 
in mmol kg-1 min -1; ptrg, percentage tubular reabsorption 
of glucose; glucin, glucose infusion rate in mg kgf mine; 
glucexc, glucose excretion in mmol kg-1 h-1] 
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Table 9.3 
Parameters of renal function during periods of 
normoglycaemia and hyperglycaemia. 
blood glucose blood glucose F sig. 
<10 mmol 1 -1 >10 mmol 1 -1 of F 
fna 0.088 (0.04) 0.063 (0.04) 2.22 NS 
fena 6.4 (4.1) 5.3 (3.7) 4.57 0.04 
naexc 0.33 (0.26) 0.19 (0.17) 4.53 0.04 
[Values are presented as mean (standard deviation); fna, 
filtered sodium in mmol kgf mint; fena, fractional sodium 
excretion; naexc, sodium excretion in mmol kg-1 h -1] 
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Table 9.4 
Parameters of renal function during periods of 
normoglycaemia and hyperglycaemia. 
blood glucose blood glucose F sig. 
<10 mmol 1-1 >10 mmol 1 -1 of F 
outin 0.67 (0.38) 0.53 (0.39) 0.92 NS 
uy 3.2 (1.9) 2.3 (1.9) 1.3 NS 
Feuv 8.6 (3.6) 8.6 (4.1) 0.01 NS 
Cosm 0.064 (0.044) 0.046 (0.04) 1.01 NS 
CH2O -0.0106 (0.025) -0.0079 (0.019) 0.37 NS 
osmexc 1.12 (0.8) 0.84 (0.75) 0.75 NS 
[Values are presented as mean (standard deviation); 
outin, ratio of fluid intake to urine output; uy, urine 
flow rate in ml kg-1 h ; Feuv, fractional urine flow; 
Cosm, osmolar clearance in ml min-1 kg-1; CHZO, free water 
clearance in ml min -1 kg-1; osmexc, osmolar excretion in 
mosm kg-1 h-1] 
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10 
SERUM BETA -2- MICROGLOBULIN 
The assessment of glomerular function in the preterm 
neonate is difficult. Clearance studies in this age group 
are often imprecise given the problems of accurate urine 
collection and incomplete bladder emptying; continuous 
infusion techniques are lengthy. A useful but approximate 
estimate of glomerular filtration rate (GFR) may be 
obtained by measuring the serum level of a constantly 
produced endogenous substance. In clinical practice, 
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despite the limitations afforded by tubular secretion, 
dependence on muscle mass and diminished production in 
patients with renal failure, plasma creatinine (PCr) is 
widely used as a screening measure of GFR. There are 
however added problems in the use of PCr in the neonate; 
PCr in newborns reflects not only muscle mass and renal 
function but is initially influenced by the maternal 
creatinine level and then falls rapidly during the first 
days of life [Trompeter 1983], making the interpretation 
of changes difficult. 
Serum beta -2- microglobulin (SB2MG) is a low molecular 
weight protein (11,800 daltons). It is produced by almost 
all nucleated human cells and almost completely filtered by 
the normal glomerulus. As excretion of SB2MG is virtually 
entirely renal, SB2MG has been proposed as a screening 
measure of GFR. The purposes of this study were to assess 
normal values for SB2MG in preterm infants, to examine the 
influence of gestational and postnatal age and the 
relationship with PCr and endogenous creatinine clearance. 
Materials and methods 
SB2MG and PCr were measured in well babies during the 
first sixteen days of life. Infants were considered "well" 
if breathing spontaneously in air, receiving enteral feeds 
and on no antibiotic or diuretic therapy. The relationships 
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between SB2MG and PCr and gestational age and postnatal age 
were initially explored using linear regression and these 
plots are presented for visual inspection. As repeated 
measures were made of SB2MG and PCr in the same infants, 
significance testing using simple linear regression would 
be inappropriate [O'Brien Smith 1987]; these relationships 
were therefore tested using multivariate analysis of 
variance. Final analysis utilised multiple linear 
regression. 
SB2MG was also measured together with endogenous 
creatinine clearance, using timed urine collections, on 26 
days in 11 infants receiving intensive care; these infants 
formed part of the group in whom renal function was studied 
in the first week of life as descibed in chapter 3 - 
Methods. Analysis was similarly using linear regression 
followed by multivariate analysis. 
Assays of SB2MG were performed using the 
Enzygnost -b2- Microglobulin reagents from Behringwerke A.G., 
W. Germany (supplied by Hoechst UK Ltd., Hounslow). 
Samples were assayed in duplicate. 
Results 
The between -batch coefficient of variation for SB2MG 
assay was 6.74% (mean SB2MG =8.204 mg 1 -1, SD= 0.553) and 
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within -batch coefficient of variation 5.8% (mean SB2MG =3.9 
mg 1 -1, SD =0.43) . 
SB2MG and PCr were measured on 59 occasions in 30 well 
babies of mean gestational age 31 weeks (median 31, range 
24 -34) and mean birth weight 1.4 kg (median 1.4, range 
0.566 - 2.288) during the first 16 days of life. SB2MG was 
measured together with endogenous creatinine clearance on 
26 days in 11 infants receiving intensive care. These 
infants were of mean gestational age 28 weeks (median 28, 
range 25 - 31) and mean birth weight 1.02 kg (median 0.980, 
range 0.68 - 1.37). The mean period of continuous urine 
collection was 1200 minutes (median 1200, range 210 - 
1800). 
The median level of SB2MG was 3.26 mg 1 -1 (mean 
3.44, 95% confidence interval 3.12 - 3.76) in well babies 
of mean postconceptional age 217 days (median 224, range 
182 - 240) . 
In the group of well babies, SB2MG showed a negative 
correlation with gestational age (Fig 10.1); multivariate 
analysis, allowing for between baby differences, showed 
this to be significant (F =3.1, p= 0.002). SB2MG was not 
influenced by postnatal age (Fig 10.2) (F =2.1, p= 0.16). PCr 
showed no correlation with gestational age (Fig 10.3) 
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(F =1.19, p =0.32) and a significant negative correlation 
with postnatal age (Fig 10.4) (F =7, p= 0.01). 
Multiple linear regression was used to construct the 
following equation predicting SB2MG from gestational and 
postnatal age: 
SB2MG (mg 1-1) = 9.28 - 0.05 PNA (days)- 0.018 GA (weeks) 
SE of estimate = 1.16 
A negative correlation was suggested between 
creatinine clearance and SB2MG (Fig 10.5). However 
multivariate analysis of variance did not confirm this 
impression (F =0.64, p =0.4) nor did logarithmic 
transformation change this relationship. 
Similarly multivariate analysis of variance did not 
confirm a relationship between creatinine clearance and 
either plasma creatinine (F =0.22, p =0.6) or the reciprocal 
of plasma creatinine (F =0.07, p =0.8). 
Discussion 
Potentially adverse influences on renal function are 
numerous in the preterm baby. In part because of the 
difficulties in monitoring basic parameters such as urine 
flow rate and changes in weight, there is often a delay in 
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recognising renal impairment until considerable derangement 
in fluid and electrolyte balance occurs or until the 
consequences of chronic renal failure are manifest. 
Despite recognised limitations [Brezis et al 1986] PCr 
is widely used as a screening measure of GFR. However in 
the newborn baby the use of PCr in this manner is further 
compounded by the fact that the neonatal level is initially 
dependent on the maternal level and thereafter changes 
rapidly [Trompeter et al 1983] with postnatal age, a 
feature confirmed in our study. The requirement to excrete 
the maternally acquired creatinine load probably accounts 
for part of the fall in PCr with postnatal age. That this 
change in PCr is at least in part independent of changes in 
GFR is borne out by the lack of correlation between 
creatinine clearance and PCr or the reciprocal of PCr. 
Within the limits of the 16 day postnatal period during 
which these measurements were made, PCr was not 
significantly influenced by gestational age. 
The relationship between SB2MG, PCr and GFR at various 
ages has been investigated by several groups. As excretion 
of SB2MG is virtually entirely renal there is good negative 
correlation between SB2MG and GFR [Brocklebank et al 
1983]. This relationship has been shown to be significantly 
better than between PCr corrected for height and EDTA 
clearance [Van Acker et al 1984]. In a previous study the 
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best fit was obtained when log SB2MG values were correlated 
with log creatinine clearance [Vincent et al 1980]. In the 
study reported here, analysis of variance allowing for the 
appreciable between baby differences, did not show a 
significant relationship between SB2MG and creatinine 
clearance. 
Other workers have shown the predictive value of SB2MG 
to be superior to that of PCr especially when glomerular 
filtration rate is moderately impaired [Wibell 1978; Van 
Acker et al 1984]. During the study period reported here 
SB2M remained relatively stable at a level influenced by 
gestational age, in contrast to PCr. This would suggest 
that SB2MG might provide a more sensitive index of renal 
impairment. 
There are limited data regarding normal values for 
SB2MG in neonates. Van Oort et al [1980] report a mean 
value of 3.54 mg 1 -1 in fourteen well babies of unspecified 
gestational age in the first week of life and 3.39 mg 1-1 
in nine babies aged 8 to 30 days; Engle and Arant [1983] 
report a mean of 5.89 mg 1 -1 in nine babies of conceptional 
age 26 to 30 weeks, falling to 3.56 mg 1 -1 at a 
conceptional age of 34 to 37 weeks (thirteen babies). 
The study reported here, like those of other workers 
[Engle and Arant 1983; Wibell 1976; van Oort et al 1980], 
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has shown a negative correlation between SB2MG and 
gestational age. This decline with age continues, reaching 
adult values of around 2 mg 11 after the first year [van 
Oort et al 1980]. Such a decline is consistent with the 
known rise in GFR with age. Aperia and Broberger [1979] are 
alone in reporting an increase in SB2MG with increasing 
conceptional age; their study is however open to criticism, 
involving as it did, acute volume loading of the infants, 
a manoeuvre known to influence GFR [Wolgast et al 1983]. 
From the data presented here, it is not possible to 
predict absolute GFR from a knowledge of SB2MG. However, it 
has been shown that, unlike PCr, the level of SB2MG 
remains stable in the first two weeks of life at an initial 
level determined by gestational age. For this reason it is 
suggested that, in the neonate, day to day variations in 




1. The mean concentration of SB2MG, measured in 30 well 
babies of 30 weeks mean gestational age, in the first 
16 days of life, was 3.44 mg 1-1. 
2. SB2MG fell significantly with gestational age but was 
stable within the first 16 days of life. 
3. In the neonate, day to day variations in SB2MG may 
provide a more sensitive screening measure of renal 
impairment. 
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Figures 10.1 - 10.2 
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Figures 10.3 - 10.4 
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ACUTE RENAL FAILURE 
With the increased intensity of care offered to 
neonates and with constantly improving continuous 
monitoring technology it is now not an infrequent 
occurrence to recognise a neonate with renal impairment. 
Acute renal failure (ARF) in its broadest terms, may be 
defined as a sudden reduction in renal function to a level 
insufficient to maintain homeostasis [Barratt 1987]. It is 
characterised by a sudden decrease in glomerular filtration 
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rate (GFR) which leads to disturbances in water, acid -base 
and electrolyte homeostasis and to the retention of 
nitrogenous waste products. In the neonate, as in other age 
groups, renal failure is divided into three categories - 
prerenal, intrinsic and postrenal failure. A diagnosis of 
prerenal failure is usually made if an oliguric infant 
responds to a fluid challenge with an increase in urine 
output. A diagnosis of postrenal failure is made if there 
is evidence of obstruction to urine flow - usually readily 
recognisable on ultrasound scanning. 
However the diagnosis of intrinsic renal failure in 
the neonate and in particular the preterm neonate, is 
difficult [Stapleton et al 1987]; there are no accepted 
diagnostic criteria. There is limited information relating 
to incidence and outcome but survivors may sustain residual 
renal damage [Anand et al 1978; Alexander & Hill 1978]. An 
evaluation of the incidence of ARF in the sick neonatal 
population, based on diagnostic criteria arbitrarily 
extrapolated from older populations would be inappropriate, 
given the relative immaturity of renal function. For this 
reason a prospective survey of 388 consecutive admissions 
to a regional neonatal referral unit was carried out to 
determine the incidence of renal impairment suggestive of 
ARF and the most useful diagnostic indices. 
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Methods 
Between March and December 1985 388 infants were 
admitted to the Regional Neonatal Intensive Care Unit, 
Liverpool Maternity Hospital. A description of this 
tertiary referral centre, population characteristics and 
standard methods of management are provided in chapter 3 - 
Methods. 
As there are no accepted diagnostic criteria for ARF 
in the neonate the initial selection of infants with 
evidence of renal impairment was based on the arbitrarily 
selected criteria listed in Table 11.1. Major criteria were 
a plasma creatinine (PCr) rising persistently over a 
minimum of two days, anuria or oligura (urine flow rate 
less than 1.0 ml kg-1 a 8 hours duration and 
a serum potassium exceeding 7.5 mmol 1 -1. Minor criteria 
were an unexplained metabolic acidosis (pH < 7.25, base 
deficit > 10 mmol 1-1) and haematuria. All selected infants 
fulfilled a minimum of one major and one minor criterion, 
but the majority fulfilled several criteria. 
In each case selection was made after normalization 
and stabilization of blood pressure. Careful attention was 
paid to maintenance of peripheral perfusion and hydration. 
An ultrasound scan of the renal tract was performed to rule 
out obstructive causes. Infants who were either anuric or 
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oliguric received a fluid challenge of 10 - 20 ml kgf of 
dextrose together with frusemide, i mg kg -1, intravenously. 
Infants who responded to such a fluid load with an increase 
in urine output were considered to be in prerenal failure. 
The following perinatal details were recorded: 
presence of perinatal asphyxia (1 minute Apgar score <3); 
antepartum haemorrhage; maternal pre eclampsia. A record 
was made of the major underlying diagnosis in each case 
together with birthweight, gestational age and postnatal 
age at the time of diagnosis. Measurement of urine and 
plasma creatinine, urea, sodium and potassium were made at 
the time of diagnosis and prior to any fluid challenge. 
Fractional sodium excretion (FeNa), renal failure index 
(RFI) and urine to plasma creatinine ratio (UCr /PCr) were 
calculated at the time of diagnosis prior to any fluid 
challenge. The formulae may be found in chapter 3 - 
Methods. 
Results 
Twenty four of 388 (6.2 %) consecutive admissions 
developed evidence of renal impairment suggestive of 
intrinsic ARF based on the criteria listed above. Eleven 
infants were anuric at the time of diagnosis and 10 were 
oliguric; 3 had a urine flow rate in excess of 1 ml kg -1 
h-1. Urine flow rate in those not anuric ranged from 0.02 - 
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3 ml kg -1 h -1 (mean 0.71, median 0.12) . Eighteen infants died 
(75% mortality) of whom 2 had ventilation electively 
discontinued. All 3 infants with non oliguric renal failure 
died. 
The range of primary diagnoses is listed in Table 
11.2. Septicaemia is the major contributor (33 %). All the 
infants in this category who died weighed less than 1500 g. 
Four babies suffered severe perinatal asphyxia (17 %); all 
were over 35 weeks gestation and all were outborn. One full 
term infant had hypoplastic left heart syndrome and 
ventilation was electively discontinued. Gestational age 
excluding these five mature infants ranged from 25 - 32 
weeks (mean 26.5, median 28). Conservative management was 
employed for each of the 6 survivors. No baby received 
peritoneal dialysis. 
Three infants, initially selected on the basis of 
oliguria, showed improved urine output after a fluid load; 
indices measured prior to the fluid load are listed in 
Table 11.3. These infants were considered to have been in 
prerenal failure. 
Sixteen babies of the 24 babies presented in the first 
48 hours of life. Among these there was a history of 
antepartum haemorrhage in 8 and preeclamptic toxaemia in 
4; 4 had suffered severe perinatal asphyxia; 2 had received 
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indomethacin within the first 4 postnatal hours; 1 was born 
to a mother suffering preeclamptic toxaemia, disseminated 
intravascular coagulation and ARF and 1 following severe 
antepartum haemorrhage; 2 had severe hyaline membrane 
disease; the remaining diagnoses were rhesus hydrops, 
massive intraabdominal haemorrhage, septicaemia, 
hypoplastic left heart syndrome and massive intracerebral 
haemorrhage; the aetiology in the remaining baby, who was 
outborn, was uncertain but possibly involved unrecognised 
perinatal asphyxia. 
Plasma creatinine, in case infants at the time of 
diagnosis, ranged from 96 - 246 umol 1 -1 (mean 155, median 
155). Fifteen of the 24 infants had PCr values at the time 
of diagnosis outwith the 5% tolerance limits for post 
conceptional age based on the data of Trompeter et al 
[1983]. Fractional sodium excretion (FeNa, %) urine to 
plasma creatinine ratio (UCr /PCr), urinary sodium 
concentration (UNa, mmol 1 -1), urine flow rate (UV, ml kg-1 
h-1) and renal failure index (RFI) for oliguric cases, non 
oliguric cases and the three babies with prerenal oliguria 
are presented in Table 11.3. 
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Discussion 
Little emphasis is placed on the recognition and 
management of renal impairment in the sick newborn baby. 
Standard textbooks of neonatal medicine deal with the 
subject in a perfunctory manner, if at all. Yet the 
incidence of the problem would appear to be high. Norman 
and Asadi [1979] reported a 6% incidence of ARF in a 
series of 314 consecutive admissions to a neonatal 
intensive care unit, a figure comparable to that reported 
here of 6.2 %. The mortality of ARF in the neonate is 
considerable. Previous reports quote mortalities of 45% 
[Norman & Asadi 1979], 60% [Ellis & Arnold 1982] and 50% 
[Mathew et al 1980]. Each of these studies related to 
infants of mean gestational age 34 - 35 weeks. The 
mortality in our series is 75% in a population with a mean 
gestational age of 30 weeks. The high mortality is probably 
due to a combination of difficulty and therefore delay in 
diagnosis, the technical problems of treatment in babies 
many of whom are of very low birth weight and because ARF 
usually occurs in severely ill infants with multisystem 
impairment. 
Only 3 cases of prerenal failure were identified. This 
is in contrast to the findings of Norman and Asadi [1979] 
that 72% of oliguric infants responded to a trial of 
volume expansion with a sustained increase in urine output. 
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This may reflect the improved appreciation in recent years 
of the high insensible water losses of the very low birth 
weight infant which may be as high as 6 -7 ml kg -1 h1 in less 
than 1000 g infants nursed under radiant warmers [Baumgart 
1982]. As in previous series septicaemia is the major 
underlying cause. Two infants were infected with s. aureus, 
one with s. epidermidis and four with gram negative 
organisms. The pathophysiology of the development of ARF in 
overwhelming sepsis is controversial but may reflect shock, 
intravascular coagulation and endotoxaemia. 
In contrast to previous reports none of the 24 infants 
had underlying urinary tract malformations, nor were there 
any cases of post renal failure. This may in part be 
attributable to the increase in antenatal ultrasound 
scanning allowing early identification and appropriate 
management before the onset of renal impairment. 
Additionally such infants often present following discharge 
from the maternity hospital leading to their admission 
directly to a renal or neonatal surgical unit. 
Two babies developed renal impairment that was 
attributable to the use of indomethacin. This is a well 
recognised hazard of indomethacin therapy [Catterton et al 
1980; Halliday et al 1979]. Elevation of plasma creatinine, 
reduction in glomerular filtration rate and fall in urine 
flow rate have all been described and would appear to 
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result from the decrease in renal blood flow induced by 
indomethacin inhibition of prostaglandin synthetase. A 
contraindication to indomethacin therapy is evidence of 
preexisting renal impairment; neither of these two infants 
had any such evidence at the time of treatment but both 
were treated within 4 hours of birth. These observations 
lend weight to the argument that the "prophylactic" 
administration of indomethacin cannot be recommended, 
particularly within the first few hours of life during 
which time major redistribution of regional blood flow is 
taking place. 
No evidence of renal impairment secondary to 
tolazoline administration was seen. Tolazoline has both 
pulmonary and systemic vasodilatory activity and it is 
likely that failure to maintain blood pressure 
with concurrent colloid infusion during tolazoline 
treatment was responsible for the association with ARF 
previously described [Trompeter et al 1981]. 
Three babies developed renal impairment in association 
with the hypoxia of severe hyaline membrane disease; two 
died, both as a primary consequence of the respiratory 
illness. 
The lack of renal functional impairment in this 
population arising as a consequence of primary infection of 
251 
the urinary tract is striking. None of the infants in this 
series had infected urine. 
Perinatal events may influence the development of 
renal impairment. Of the 16 cases identified in the first 
48 hours of life, 8 had a history of antepartum 
haemorrhage, though in only 1 did the renal impairment 
appear directly attributable to the haemorrhage. One infant 
with haematuria and intractable oliguria who was also 
hypertensive, was delivered of a mother who had herself 
developed ARF and disseminated intravascular coagulation 
secondary to pre eclamptic toxaemia. Little is known of 
renal function in infants born to pre eclamptic mothers 
though such infants have been described as having a 
significantly higher mean blood pressure in the first 20 
minutes of life than a control group [Miller et al 1983]. 
Of indicators of renal impairment, changes in plasma 
creatinine and urine flow rate are at present used most 
frequently by the neonatal clinician but there are 
unfortunately problems in the interpretation of both these 
parameters in the newborn baby. The neonatal plasma 
creatinine level is initially dependent on the maternal 
level and changes rapidly during the first week of life. A 
sustained rise in plasma creatinine is indicative of a fall 
in glomerular filtration rate, but glomerular filtration 
rate is also changing at a rate dependent on both 
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gestational and postnatal age [Trompeter et al 1983]. 
Standard laboratory methods of plasma creatinine 
measurement may include the assay of non creatinine 
chromogens, the presence of which are significant when 
small changes are being considered. 
Oliguria resistant to volume repletion is generally 
considered indicative of intrinsic renal failure but normal 
values for urine flow rate in preterm infants are poorly 
documented [Jones et al 1972]. 7% of infants fail to void 
during the first 24 hours of life [Kramer & Sherry 1951] 
and neonates do not empty their bladders completely on 
voiding [Osborne 1977] rendering external urine collections 
of short duration inaccurate. There is also the question of 
what constitutes oliguria in the preterm infant. Solute 
retention might be expected to a urine flow rate 
of less than 1 ml kg -1 h -1 in the presence of an average 
renal solute load of 15 mosm kg body weight-1 day-1 and an 
average maximum urinary concentration of 500 - 700 mosm kg 
water-1 [Edelmann et al 1960] but babies in their first day 
of life have considerably smaller solute loads and a more 
appropriate figure may be 0.5 ml kg -1 h-1. 
Three babies had urine flow rates in excess of 1 ml 
kg-1 h -1. All 3 were very oedematous and had haematuria; 2 
were hyperkalaemic and of these 1 had a severe metabolic 
acidosis; only 1 had a raised plasma creatinine. Grylack et 
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al [1982] described the occurrence of non oliguric ARF in 
the newborn but their conclusions are less than convincing 
based as they are on an acceptance of a raised BUN as 
sufficient evidence of renal impairment. Non oliguric renal 
failure is believed to result from lesser degrees of 
tubular insult and to have a more favourable prognosis 
[Chevalier et al 1984]. However, in the present study, all 
3 infants with non -oliguric ARF died. It is likely that 
with improved methods of monitoring renal function in 
extremely tiny babies the incidence of such lesser degrees 
of renal insufficiency will be found to have been 
underestimated. 
Thirteen of the 24 infants had a serum urea within the 
normal range at the time of diagnosis. Measurement of serum 
urea is probably of little value in the newborn influenced 
as it is by numerous non renal factors. Misleading 
elevations in the presence of normal renal function may be 
seen in catabolic states such as sepsis and trauma and in 
the presence of sequestered blood, areas of tissue necrosis 
and haemoconcentration. Conversely, the higher anabolic 
state of the healthy newborn suggests that relatively 
smaller increments in plasma urea may reflect renal 
impairment. 
In prerenal failure avid reabsorption of sodium and 
water results in urine of low sodium content and high 
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UCr /PCr while in established acute tubular necrosis the 
inability to conserve sodium and water results in urine of 
high sodium content and low UCr /PCr. These observations 
form the basis for the use of FeNa and RFI in 
differentiating prerenal from renal failure in older 
children and adults and such criteria have been applied to 
the neonate [Anand 1982; Aschinberg et al 1977; Engle 1986; 
Stapleton et al 1987]. 
Mathew et al [1980], in a study involving neonates of 
predominantly greater than 32 weeks gestation, suggest 
that a FeNa of 2.5% or greater is suggestive of renal as 
opposed to prerenal failure. A cut off FeNa of 3% has also 
been suggested [Norman & Asadi 1979], but in their study 
of 20 infants with ARF, only 7 were of less than 35 weeks 
gestation. Clinically well neonates of low gestational 
may have FeNa values of up to 6% [Siegel & Oh 1976]. 
Similarly several authors suggest that a RFI of 
greater than 2.5 [Ellis & Arnold 1982; Mathew et al 1980], 
UCr /PCr of less than 20 and a urinary sodium 
concentration exceeding 40 mmol 1 -1 [Medani et al 1979] 
are indicative of intrinsic renal failure. 
In the present study all three infants with prerenal 
oliguria had values for FeNa of less than 2.5 %, a renal 
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failure index of less than 2.5 and UCr /PCr exceeding 20 but 
urinary sodium excretion was high. 
These parameters were measured in 7 of the 10 babies 
with volume repletion resistant oliguria (Table 11.3). In 
this group urinary sodium is uniformly greater than 40 mmol 
1 -1 but examination of FeNa, UCr /PCr and RFI appears to 
distinguish two subgroups with demarcation values of 
approximately 3 %, 20 and 5.5 respectively. Three of the 6 
survivors came from the subgroup with low FeNa, high 
UCr /PCr and low RFI, values which might be interpreted as 
suggestive of volume responsive prerenal oliguria; patient 
2, who received indomethacin within the first four hours of 
life, patient 3, a 30 week rhesus hydrops, and patient 4, 
with severe hyaline membrane disease. The fatality, patient 
1, had a pseudomonas septicaemia. 
It is possible that the intractable oliguria in these 
infants with relative preservation of tubular concentrating 
ability reflects a decrease in GFR perhaps brought about by 
intense renal vasoconstriction, as has been suggested as 
occurring in infants with severe hyaline membrane disease, 
without intrinsic renal damage. Certainly low FeNa values 
have been described in clinical settings associated with 
marked glomerular hypoperfusion and avid renal tubular 
sodium reabsorption [Zarich et al 1985] such as congestive 
cardiac failure, with altered intrarenal haemodynamics such 
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as caused by indomethacin and following acute intra or 
extrarenal obstruction such as caused by haemoglobin and 
myoglobinuria. 
In summary intrinsic renal impairment in the neonate 
is most likely to be seen after severe perinatal asphyxia 
in mature infants and in overwhelming septicaemia. 
Indomethacin therapy poses a particular hazard. 
Difficulties lie in detecting intermediate forms of damage. 
It is suggested that to the accepted spectrum of prerenal 
failure or hypoperfusion states, medullary ischemia and 
cortical ischemia be added oliguria resistant to volume 
repletion with intact tubular function. 
Assessment of renal function is likely to be 
misleading if based on either changes in urine flow rate or 
on calculated indices of function in isolation. Healthy 
preterm neonates may have a high urinary sodium 
concentration and fractional sodium excretion and given 
both the problems in interpreting urine flow rates 
discussed above and the not insignificant difficulty in 
accurately collecting urine from neonates, meticulous 
attention to fluid balance and body weight remains the 
cornerstone of management. Early diagnosis at present 
depends on recognition of failure to achieve the normal 
postnatal fall in plasma creatinine. 
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Conclusions 
1. The incidence of acute renal failure, assessed 
prospectively in 388 consecutive admissions to a 
regional tertiary neonatal referral centre, was 6.2% 
(24) . 
2. Overwhelming septicaemia was the commonest underlying 
cause, occurring in 8 infants (33 %). Perinatal 
asphyxia was the commonest cause in mature infants. 
3. There was a 75% mortality. 
4. Eleven babies presented anuric, 10 oliguric and 3 
were non -oliguric. The incidence of non -oliguric renal 
failure may have been underestimated. 
5. In the differentiation of prerenal from renal failure 
in the oliguric infant, a urinary sodium concentration 
exceeding 40 mmol 1-1 is highly sensitive but of poor 
specificity; a FeNa exceeding 3% is poorly sensitive 
but highly specific. 
6. The most useful screening measure would appear to be 




Selection criteria for infants with renal impairment 
Major criteria 
Rising plasma creatinine 
Anuria or oliguria 
Hyperkalaemia 
Minor criteria 
persistently rising over a 
minimum of two days; the 
rise outwith the 95% 
tolerance limits for the 
assay in our laboratory. 
oliguria - < i ml kg -1 h-1; 
present for a minimum of 
8 hours. 
unhaemolysed sample; 
confirmed on repeat 
testing; >7.5 mmol 1-1 
Metabolic acidosis pH < 7.25; base deficit > 10 
Haematuria 











maternal PET /DIC /ARF 
hypoplastic LHS 
total 
number of deaths 
babies ( %) 
8 (33) 7 
4 (17) 3 
3 (12.5) 2 
4 (17) 4 
2 (8) 1 
1 ) 0 
1 ) (12.5) 0 




Parameters of renal function in infants with evidence of 




FeNa UCr/PCr UNa Uy RFI 
1 2.77 22 114 0.5 5.2 
2 0.75 51 48 0.12 0.9 
3 0.9 35 43 0.02 1.2 
4 1.5 20.7 44 0.05 2.1 
5 5.48 17 131 0.05 7.7 
6 11.5 6.6 100 0.55 15.2 
7 64.5 1.36 136 0.1 100 
(non oliguric) 
8 44 2.4 160 2.6 66.7 
9 2.6 21 75 3 3.6 
(prerenal) 
10 0.9 29.9 44 0.2 1.5 
11 1.4 38.4 74 0.2 1.9 





Justification for the approach adopted. 
A possible criticism of this study is that 
observations have been made and conclusions drawn from an 
essentially unselected group of infants with differing 
clinical characteristics. Nevertheless this approach can be 
justified in that it is also true that these infants form 
a clearly definable group, that of the infant of less than 
34 weeks gestation with respiratory distress syndrome. Such 
infants form the major work load of neonatal intensive care 
units and a reluctance to study them directly because of 
the difficulties of controlling the number of clinical 
variables involved has resulted in the equally questionable 
application of data extrapolated from clinically different 
populations. 
Duration of observations. 
The infants were studied for differing lengths of 
time. Though not ideal, that this was unavoidable is a 
reflection of the practical difficulties involved. One in 
three admissions to this neonatal unit of babies of less 
than 1500 g birthweight were outborn, thus limiting the 
number it was possible to study from birth; only males were 
studied because of the need for accurate urine collection; 
263 
the study was conducted during a full time clinical 
appointment and could not therefore be supervised as 
closely as desired - this meant again for example that 
babies could not always be studied from birth and that 
breakdown of the skin of the perineum or leakage of urine 
from the collecting system meant ending that particular 
study; only one set of collecting apparatus was available 
allowing only one baby to be studied at any given time; the 
death of an infant obviously terminated a study as did the 
introduction of enteral feeds, loss of intraarterial access 
and transfer back to the referring hospital. 
Statistical approach 
A more useful approach than refusing to study 
clinically complicated subjects is to choose the method of 
statistical analysis with care. This underlies the use of 
multivariate analysis of variance in this study. The use of 
multivariate analysis of variance is essential when dealing 
with several interrelated variables [Hand & Taylor 1987]. 
Controlling for potentially confounding variables as done 
in this study may have weakened the chances of detecting an 
important relationship but it will also have minimised the 
chances of claiming significance when in fact none exists. 
For a small study this is an important consideration. It is 
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fair to say therefore, that the conclusions from this study 
are robust enough to merit further, controlled studies in 
selected groups of infants. 
Glomerular filtration rate 
Endogenous creatinine clearance was chosen as the 
method for measuring glomerular filtration rate as this 
would be readily applicable in a clinical setting. Two 
potential problems, that of extrarenal clearance and 
tubular secretion of creatinine were unlikely to be of 
relevance in the preterm neonate; a third, that of the 
presence of non -creatinine chromogens in plasma would 
appear from the literature to be minimised by the use of a 
kinetic reaction rate method of analysis [Schwartz et al 
1987]. The Beckman autoanalyser used in this study 
utilises such a method [Hicks et al, 1979; Cottrell & 
Frings, 1979] and is also in wide use in hospital 
laboratories. Since the work and analysis for this study 
were completed it has become apparent that the presence of 
non -creatinine chromogens may be more of a problem in the 
preterm neonate than hitherto appreciated (Coulthard MG, 
personal communication of unpublished observations). 
Virtually all of the relevant literature should therefore 
be regarded with caution and in future studies a method of 
265 
creatinine assay not subject to interference, such as high 
pressure liquid chromatography (HPLC) or dilution mass 
spectroscopy, should be used. As far as this study is 
concerned, the same considerations apply to absolute 
measures of creatinine clearance. They do not however 
detract from the observation that following approximate 
correction for the presence of non -creatinine chromogens, 
creatinine clearance in this group of infants with 
respiratory disease was similar to comparable published 
measurements made in well infants. 
Creatinine excretion. 
Non -creatinine chromogens do not cause interference in 
urine samples and the measurements of creatinine excretion 
rate are thus reliable. A particular strength of the study 
is that accurate, timed urine collections were made over 
prolonged periods, thus minimising the problem of 
incomplete and variable voiding. The conclusion that 
creatinine excretion per unit weight increases between 25- 
34 weeks gestation, a conclusion that is at variance with 
certain published opinion, is strengthened by the meta - 
analysis incorporating data from the literature. Estimates 
of muscle mass derived from creatinine excretion rate are 
shown to be in close agreement with anatomical measures. 
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Serial measurements of body composition are poorly 
conducted in most newborn populations despite the fact that 
graduates from intensive care are liable to impaired growth 
for a variety of reasons. This simple method for estimating 
muscle mass should have useful application in clinical 
management. 
Urine flow rate. 
Urine flow rate on the first day of life was very 
often less than 1 ml kg -1 h-1 and was insufficient given the 
frequent concurrence of of inappropriate weight gain. The 
babies in this study often developed an inappropriate 
expansion of the extracellular space as shown by early 
weight gain, positive sodium balance and a normal plasma 
sodium concentration. A poor urine output is frequently 
missed in clinical practice because it is not monitored 
adequately. Equally, that a given urine output is 
insufficient is often not appreciated because babies are 
not weighed frequently enough and weights are not obtained 
net of attachments such as electrodes, endotracheal tubes 
and cannulae. Suggested explanations for the low first day 
urine flow rate have been that a urine output of less than 
1 ml kg -1 h -1 is adequate given the low first day solute 
load, that it reflects the high circulating level of ADH 
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known to occur around the time of birth or that it reflects 
transiently impaired renal function. An alternative 
explanation is suggested by the observations of this study; 
namely that it is a response to an excessive salt intake. 
This hypothesis might be tested by comparing first day 
urine output in matched groups receiving different amounts 
of sodium. 
The frequent observation of hyperosmolality should 
cause concern. Values around 300 mosm 11 were often seen 
and would be more than sufficient to provoke the release of 
ADH and further impair water excretion. 
Sodium. 
not acceptable to regard the handling of sodium 
in the preterm baby as simply a function of immaturity. 
Changes in the handling of sodium are crucial to postnatal 
adaptation. The known contraction in extracellular fluid 
volume that occurs following birth must be accompanied by 
a loss of sodium; this study has shown the importance of 
considering the immediate postnatal period, during which 
cardiopulmonary adapation occurs, separately from 
subsequent periods when the problems of prematurity may be 
considered in relative isolation; the trigger transiently 
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imposing sodium loss onto the normal response of the 
growing organism to retain sodium is not known. The 
observations of this study suggest that the trigger is some 
function of cardiopulmonary adaptation. Studies are 
currently in progress to explore this further. 
Glucose. 
The inadvisability of extrapolation of data from other 
age groups is underlined by the observation that 
hyperglycaemia of the degree seen in this study did not 
lead to an osmotic diuresis. This has also been noted by 
other workers [Coulthard MG, unpublished observations] but 
needs to be more widely recognised as advice to increase 
fluid intake in the presence of hyperglycaemia and 
glycosuria is often found in textbooks of neonatology. The 
finding in this study that hyperglycaemia was associated 
with sodium retention and the hypothesis that this may be 
the result of a redistribution of blood flow during 
hyperglycaemia to the salt retaining inner cortical 
nephrons requires further evaluation. A direct, controlled 
study would not however be possible because it would be 
unethical to deliberately subject preterm babies to 
hyperglycaemia. 
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Beta -2- microglobulin /acute renal failure. 
Renal failure would appear to be as common in the 
newborn population as previously reported, though the peak 
occurrence has shifted to infants of greater immaturity. A 
major problem remains that of diagnosis and definition. 
That this should be so is not surprising given the limited 
knowledge of normal renal function. Changes in plasma 
creatinine may be of more value when it is possible to 
measure true creatinine readily though the normal 
physiological changes in the immediate postnatal period 
will always adversely affect sensitivity and specificity. 
Monitoring serum beta -2- microglobulin may be a more useful 
approach. Senstive markers of tubular damage are also 
required to allow evaluation of, for example, damage 
following asphyxial insult or exposure to nephrotoxic 
agents. The measurement of urinary beta -2- microglobulin in 
this study was not found to be helpful because the accuracy 
of the assay was dependent on immediate correction of 
urinary pH and therefore affected by any delay in voiding. 
More studies of alternative urinary markers such as N- 
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